CA2238614A1 - Cartridge-based drug delivery device - Google Patents

Cartridge-based drug delivery device Download PDF

Info

Publication number
CA2238614A1
CA2238614A1 CA002238614A CA2238614A CA2238614A1 CA 2238614 A1 CA2238614 A1 CA 2238614A1 CA 002238614 A CA002238614 A CA 002238614A CA 2238614 A CA2238614 A CA 2238614A CA 2238614 A1 CA2238614 A1 CA 2238614A1
Authority
CA
Canada
Prior art keywords
cartridge
skin
drug
delivery
needle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002238614A
Other languages
French (fr)
Inventor
Joseph Gross
Izrail Tsals
Gilad Lavi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Elan Medical Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Medical Technologies Ltd filed Critical Elan Medical Technologies Ltd
Publication of CA2238614A1 publication Critical patent/CA2238614A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/14526Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons the piston being actuated by fluid pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1454Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons spring-actuated, e.g. by a clockwork
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/14252Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/1426Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with means for preventing access to the needle after use
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/158Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
    • A61M2005/1581Right-angle needle-type devices

Abstract

A liquid drug delivery device (40) is adapted to be adhered to the skin of a subject by a base member (49) defining a skin-contacting surface (50) having an adhesive coating. A columnar cartridge (48) serves as reservoir for the drug and is incorporated in a housing which is connected to the base member (49) such that in use the longitudinal axis of the cartridge (48) is disposed substantially parallel to the skin-contacting surface (50). A delivery needle communicating in use with the interior of the cartridge (48) penetrates the skin of the subject when the housing snaps downward relative to the base member (49). This action also causes the actuation of a citric acid (42)/sodium bicarbonate (43) gas generator which generates a gas to move a piston (41) within the cartridge (48), compressing the drug compartment. This compression causes a stopper to be penetrated by a conduit in communication with the delivery needle, allowing the drug to be ejected from the compartment through the needle and into the subcutaneous tissue of the subject.

Description

WO 97/21457 PCT/IE9t~/'C 1 Description Cartrid~e-based dru~ delivery device Technical Field This invention relates to devices for subcutaneous, intravenous, s intramuscular or intradermal delivery of drugs to a subject.

Background Art The conventional method of parenteral ~tlmini~tration of a drug to a subject is by injection using a hypodermic syringe. A number of dif~lculties associated with these syringes have led to ~ile~ s to derive 10 more advantageous drug delivery devices. Syringes are not generally advocated for use in self ~-lmini~tration by patients because of the dangers of embolisms arising from the introduction of air bubbles ;nto the bloodstream, incorrect dosing, and the accidental infection of third parties after use of the syringe. In any event, syringes cannot be used lS by children or by many elderly patients, and the use of syringes is very tr~lm~tiC for the large number of people who are needlephobic to a greater or lesser extent.

In trying to provide improved syringes, a number of inventors have focussed on the provision of a pre-filled syringe or a pre-filled 2C ampoule for use in a syringe, as these devices can be useful in addressing the problems of incorrect dosage or incorrect filling of syringes. Furthermore, some syringes have been provided with expelling means which autom~tie~lly deliver the drug from the syringe body or ampoule, rather than relying on a conventional syringe 2~ mech~nicm which can be difficult to manipulate in a smooth uniform fashion with one hand. Examples of such devices are the syringe disclosed in U.S. Patent No. 2,390,246, the ampoule disclosed in U.S.
Patent No. 2,445,477 and the disposable needleless hypodermic injector disclosed in U.S. Patent No. 3,527,212.
-WO 97/214~;7 PCT/lhS. ~_C ';

The devices of U.S. Patent Nos. 2,390,246 and 2,445,477 still re~uire the p~ti~nt to correctly ~imini.~ter the injection, which may be difficult for some patients, and which some p~ti~nts may refuse to do ~ec~llse of a fear of needles. Furthermore, each of these docl~men~
discloses a very sophisticated and complex me~h~nic~l arrangement ~or activating the expelling me~n~ The devices would, in consequence, be prohihitively difficult and expensive to mass produce and would be prone to failure due to device complexity.

The device of U.S. Patent No. 3,527,212 elimin~tes ~e use of 10 needles and has a construction with fewer parts, but manufacture would still be difficult and expensive as the needleless injection of a drug requires the drug to be provided to the skin at pressures in excess of 400 lb/in~ (27.5 bar). Thus, the device must be provided wi~ a propellant at such a pressure when it is manufactured, and this pressure 15 must be m~int~ined throughout the shelf life of the device in a compartment which is bounded by a membrane strong enough to with.~t~nd the pressure but which is nevertheless easily rupturable by the m~ml~l depression of a plunger. Again, it will be appreciated that these requirementc lead to a product which is quite difficult and 20 expensive to m~mlf~cture.

Needleless devices have their own problems, since their correct use requires a certain degree of dexterity and strength. The device must be held firmly against the skin at the correct angle. Correct delivery of the drug requires it to be propelled at high pressure 2s through the skin, so if the device is held at an incorrect angle or is not held firmly enough, then there is a strong likelihood that ~he medic~ment will not pass through the skin but will be dispersed into ~e air. As needleless injectors are usually quite buLky, the dexterity issue may be far from trivial from many patients.

Another limit~tion which is associated with each of the devices ~felled to above is ~at they can only be used for bolus a~mini.~tration, i.e. the imme(li~te in3ection of a single entire dose. This is not sllit~ble for all therapies, as it may be preferred in many cases to provide a WO 97/21457 PCT/IE~)Gi'li~t~

continuous infusion of a drug both to avoid toxicity problems and to provide improved efficacy. Furthermore, if a drug is provided as a bolus injection, it may be necess~ry to inject a number of doses per day.
.

A number of infusion pumps are known, such as those described in U.S. Patent No. 4,886,499 and our own WO 95/13838. In general, however, infusion pumps are far more sophistic~te~l and complex than syringes or syringe-based injectors, with the result that they are unable to compete commercially with conventional injectors.

lo The problems associated with complex devices should not be underestimated from a manufacturing point of view. Not only does it become incre~in~ly difficult and expensive to mass-produce a device having large numbers of components, but the reliability of such devices is inherently worse. To illustrate this point, if each component in a production line is tested and found ~o have, on average, a reliability of 99% (1 failure in every 100), then devices having only 5 components can be predicted to have expected reliability rates of 95% (given by 0.995). Devices having 1~), 20, and 50 of such components can be expected to have reliability rates of 90%, ~2% and 61%, respectively.
Evidently the safety implications of increasing device complexity cannot be ignored when considering drug delivery devices in particular.

Therefore, among the objects of the present invention are the provision of a drug delivery device which: is capable of delivering a 2S pre-set dosage of drug to a subject; is suitable for use in self-~lmini~tration by p~ti~nt~ (inclll~l;n~ young F~tients and elderly patients); does not require the patient to consciously insert a needle into the skin; has a construction sufficiently simple to enable it to be mass produced at least as cheaply as (and in most cases more cheaply than) ~ 30 prior art bolus injectors described im the docllmPnt~ referred to above and subst~nti~lly more cheaply than prior art infusion pumps; can provide either a bolus injection or can perform a continuous or controlled infusion; and overcomes the disadvantages associated with WO 97/21457 PCT/IE96~W--5 the conventional hypodermic syringe. Further objects and advantages of the invention will become apparent from the description given below.

Disclosure of Invention s Accordingly the invention provides a liquid drug delivery device comprising a base member ~lefînin~ a skin-cont~etin~ surface for application to the skin of a subject, a colllmn~r cartridge serving as reservoir for the drug and which is connected to the base member such that in use the longitudinal axis of the cartridge is disposed subst~nti~lly 0 parallel to the skin-contacting surface, a delivery needle comml-nicating in use with the interior of the cartridge and adapted to penetrate the skin of the subject, and means for expelling a drug out of the interior of the cartridge and through the skin of the subject via the delivery needle.

Bec~llse the device has a skin-contacting surface and a columnar cartridge disposed subst~nti~lly parallel thereto, the device can be applied to the skin in order to effect delivery of the drug. One can use a conventional coll-mn~r cartridge such as a refill cartridge of the type used in "pen-type" insulin injectors, or it can be any other type OlC
20 colllmn~r cartridge. Such cartridges may suitably be cylindrical glass or plastic cartridges, for example, and would preferably be extremely inexpensive to m~mlf~cture. The configuration of the device means it can be applied to the skin, and delivery can be effected in a single step application, as will be described below. The configuration which uses a 25 skin-cont~ctin~ surface and a delivery needle which penetrates the skin of the subject means that far less dexterity is required in ~dmini~tering ~e drug than is the case with many bolus injectors, incln~ling those referred to previously.

The term "cartridge" as used herein denotes a coll-mn~r 30 cont~in~-r or vessel for a liquid, ~refel~bly formed of glass or plastic.
The term "cartridge" does not necessarily imply a component which is removable from the device as a whole, or a component which is CA 022386l4 l998-05-25 WO 97/21457 PCT/IE~Si.'11~ ~ F

replaceable, although the cartridge may in fact be removable or replaceable.

The term "liquid drug" includes drugs which are in the form of liquids, a solutions, suspensions, or flowable gels.
3 Suitably, a portion of ~he interior of the cartridge defines a drug compartment for the drug, the drug being expelled from ~e compartment by a piston actuated by the expelling me~n~.

It will be appreciated that when a piston is employed to expel the drug the col~lmn~r cartridge may be cylindrical or it may be of generally cylindrical form (the cross section need not be circular).
Indeed, one can envisage cases where a cylinder having a slight lon~ ldin~l curve would be employed for clesi~n reasons. Such cartridge shapes are perfectly acceptable provided of course that the piston is still effective to expel the drug from the drug compartment.

Preferably, the interior of the cartridge also defines a chamber housing the expelling means, such that the ~ctll~tion of the piston by the expelling means causes the expansion of said chamber and the contraction of said drug compartment.

This arrangement is advantageous because the cartridge (which 20 may be as simple as a glass or plastic cylinder) can house both the drug and the expelling means. Indeed, a number of embo~lime~ts described in detail below illustrate this arrangemen~ By incorporating the expelling means into the cartridge, one obtains significant savings in space, thereby m~king the device as small and unobtrllsive as possible.
25 This is particularly important if the device is to be worn for an e~cten-led period of time.

One can also envisage embo-liments in which the expelling means is incorporated within the cartridge but the chamber cont~ining the expelling me~n~ is in fact also the drug cornpartment and the expelling 30 means serve to pull the piston and contract ~e chamber (and drug 4~7 PCT/IE9~ 'C G C ~~

compartment). There are pr~cticAl disadvantages associ~te~l with this arrangement given that the expelling means must be sterile and inert if it is in contact with the drug. For pr~ctic~l purposes it is yl~fer~ble to use the piston to separate an expansible chamber for the expelling s means and a contractible drug co~ a~ ent for the drug.

~ uitably, the device is provided with a conduit enabling fluid co~ -- -ic~tion to be established in use between the drug colllya~ ent and the delivery needle.

Preferably, the conduit exten~ls at subst~nti~lly right angles from 10 the delivery needle.

By having a delivery n~eAle having a conduit extending at subst~nti~lly right angles from the delivery needle, the conduit can access the drug compartment through an end of the cartridge (in a direction purposely parallel to the skin-cont~ting surface), and the 15 delivery n~erlle can deliver drug passing out of the drug compartrnent through the conduit by penetrating norrn~lly through the skin. Clearly, an angle of exactly 90~ is not re~uired (although it may be preferred), but one would envisage that dle conduit extends from the delivery needle at 80-100~, preferably 85-95~ (and most preferably 90~). This 20 allows the n.oe~lle to penetrate the skin vertically and simlllt~n~.ously allows col--"~ ic~tion to be established between this delivery needle and a cartridge lying exactly parallel to the skin.

Preferably, the conduit is integral with the delivery needle.

~uitably, the delivery needle and the conduit form part of a 2s needle assembly mounted on an end of the cartridge.

In preferred emboclimPn~s, the device further comprises a mech~ni~m for ~ct-l~tin~ the expelling means.

WO 97/21457 PCT/IE~ C-~;

Suitably, the col-n~ction between the cartridge and the base member allows relative movement t~erebetween from an initial configuration to a working configuration.

Preferably, said relative movement operates the mec~h~nism for 5 ~ctll~tin~ the expelling m~.~n~.

In other words, the device can be in an initial con~figuration in which it is m5/int~ine.cl during storage or before use, and then by moving the cartridge and base member relative to one another, the device is primed for use and the expelling means is ~ctl-~te-l.

lo Further, preferably, said relative movement causes the delivery needle to project through the plane of the skin-contacting surface and thereby penetrate the skin in use.

This arrangement allows the skin-cont~rting sl~ re to be placed on the skin (this surface being suitably provided with an a&esive 15 coating or the device being provided with some other means of ret~ining the skin-contacting surface on the skin), and then a relative movement between the base mPmber and the cartridge causes the penetration of the skin (and optionally, the actuation of the expelling means).

Further, preferably, said relative movement causes the establi~hmPnt of fluid colnmllni~tion between the drug compartment and the delivery needle.

If the relative movement between the cartridge and base member accomplishes all three ~r~rellc;d acts, namely the actuation of the 2s expelling me~n~, the penetration of the skin by the delivery needle and the estab~ishment of fluid commllnication between the drug compartment and the delivery needle, then one can achieve a single-step application of the device, whereby some movement between the cartridge and the base member achieves the delivery of drug in a safe and predictable m~nn~.r. The rela~ive movement may be rotational or WO 97/21457 PCTIIE;YG~

tr~n~l~tional. For example, the cartridge could be incorporated in a first section of a housing which is screwed relative to a sec~n~l section of the housing (the seco~.1 section incorporating the base member~, with this screwing movement initi~tinp delivery.

s Alternatively, the connection between the cartridge and the base member is provided by a hinge enabling the cartridge and the base member to be pressed towards one another from a spaced-apart initial configuration to an adjacent wor~ g configuration.

Suitably, the skin-cont~ctin~ surface is provided with an ~ellu through which the delivery need}e extends in use.

I~ the cartridge is movable relative to the base member, the needle can be retracted in the initial configuration and it can extend through the skin-cont~cting surface in the working configuration; this allows for a device in which the needle is never seen by the subject in normal use. This is particularly suitable for nee-llephobics or people who, while not actually needlephobic, are upset to a greater or lesser degree by needles and injections.

Preferably, an end of the cartridge is provided with a stopper and the conduit and stopper are movable relative to one another to allow the conduit to penetrate through the stopper and thereby establish said co.~....-..~ic~tion.

The conduit can be pointed or blunt, provided that it is able to penetrate through and establish commllnication with the interior of the cartridge.

2s This arrangement is advantageous bec~llse it allows the contents of the drug compartment to be m~int~in~ in a sterile condition until the moment when co"~,n-..-ication is established between the delivery n~.e-lle and the drug compartment. As described above, and as f~lrther described in detail below, the device can be applied to the skin and a 30 single action can cause establi.chm~nt of co.~ -.ication between the WO 97/21457 PCT/IE~)6/~

delivery nee~le and the cartridge at roughly the same moment as the delivery n~e~lle penetrates the skin. Thus, sterility is ensured from dle point of view of the p~ti~nt The skin-contacting surface may be covered before use by a release liner of some sort.

s According to one embo~liment, the position of the nee(lle ~se-mhly is fixed wi~ respect to ~e cartridge, and ~e stopper is movable relative to both the cartridge and ~e needle ~sernbly.

Suitably, the ~c~l~fion of the expelling means causes the stopper to be pressed onto and penetrated by the con-lllit lo According to another embo(lime~t the position of the stopper is fixed with respect to the cartridge, and the needle assembly is movable relative to both the cartridge and the stopper.

In certain embodiments, the expelling means comprises a pre-compressed spring.

Preferably, the m~ch~ni.~m for actll~ting the expelling means comprises a catch which when released enables the pre-compressed spring to relax.

Most preferably, a relative movement between the cartridge and the base member from an initial configuration to a working configuration causes the catch to be released.

Alternatively, the expelling means comprises a gas generator which generates a gas when two or more reactants are brought into contact.

Suitably, the gas generator comprises at least one liquid.

Advantageously, the gas generator comprises the components of an effervescent couple.

WO 97/2t457 PCT/IE~ Q~

Again, alternatively, the expelling means comprises a material which swells in the presence of a liquid, and also comprises a supply of said liquid.

Suitably, in such cases, said material is a swellable gel and said s liquid is water.

Suitably, in embo~lime~ where the expelling means comprises a liquid as an essçnti~l co~ o,lent, and when the cartridge and base member are movable relative to one another as described above, said liquid is contained within a l,l~Lulable compartment and the mech~ni~m 10 for actll~tin~ the expelling means comprises a penetrating member, the penetrating member and the lu~Lulable co~ alllllent being moved relative to one another upon the relative movement of the cartridge and the base member, so as to cause the penetration of said 1 ~ urable compartment and the actuation of the expelling means.

Suitably, the device further comprises a snap m.oçh~ni.cm which m~int~inS a stable initial configuration and a stable working configuration and which when ~c~l~te-l causes the device to snap from said initial configuration to said working configuration.

Further, suitably, the device is provided with resilient means biasing the device to said initial configuration and means for diseng~gin~ said snap mech~ni~m when delivery has been completed.

~lcfel~bly, said ~ eng~ing means comprises a member linked to said piston such that when the piston has completed the expulsion of drug from the drug compaltlllent, said member is c~l~sed to move and said movement causes the ~ en~ement of said snap mech~ni~m, such that said resilient means causes the device to resurne said initial 4 configuration.

Thus, if the device is provided with both a snap mt~ch~nicm and a spring biasing the device to the initial configuration, the ~-ltom~;c release of the snap mec~ni~m after completion of delivery causes ~e WO 97/21457 PCT/IE96/OOQ~

spring to return the device to the initial configuration (being no longer held in the working configuration by the snap mech~nicm). Suitably, this movement will cause the retraction of dle delivery nee~1lç from the skin, optionally to a point where it is no longer visible.

s This action (which might be observed by the cartridge S~ g away from the base mtomber~ informs the subject tnat delivery has been completed and, in certain cases, retracts the nee~ to the point where it is concealed from the subject both before use and after use.

Sui~ably, said relative movement is a pivotal movement.

Preferably, the cartridge and base member are connected by means of a hinge.

According to a further embodLiment, said delivery nee~llp pro~ects through the plane of the skin-cont~rtin~ surface at or outside of the periphery of the skin-cont~cting surface.

It is preferred if the delivery neeflle projects through the plane at a point on the periphery of the skin-contacting surface distal from ~e hinge, as this means that the needle will jab through the skin more quickly than it would if it was located right beside the hinge. The quicker the needle pierces the skin tlhe less painful it is likely to be for the subject.

According to one embodiment, the delivery needle is in the shape of a segment of arc of an im~gin~ry circle, said circle having a radius equal to the tli~t~n~e between the delivery needle and the hinge and lying in a plane which is subst~nti~lly normal to ~e plane of the skin-contacting surface.

- This embodiment with a curved needle is useful where the needle is llmlsll~lly long, as a pivotal movement such as that provided by a hinge causes the needle to have a lateral component of velocity when it is penetrating the skin. This lateral movement of the needle causes the WO 97/21457 PCT/IE~/C-0 stretching or te~rin~ of the skin in e~treme cases, and in any event leaves a bigger entry wound than would othen,vise be the case. The ~limet-~ions of the im~,~in~ry circle given above ensure that the body of the n~e~ exactly follows the point of the n~erlle on its path into the subject.

Alternatively, the delivery nee~ may be straight. This is preferred in embodiments in which delivery nee-lle moves straight down into the skin, or in embotliment~ where the leng~ of ~e delivery needle or ~e radius of the im7/g;n~ry circle means that the needle has a 10 negligibly small lateral component of movement upon entering the so skin that it would be uneconomical or unnecessary to make a curved needle. Tndee-l, in many cases, it will be lmnPcessary for the needle to be curved.

Typical medic~mer2t~ suitable for use with the device according 15 to the invention inclll~lP peptides, proteins or hormones such as insulin, calcitonin, calcitonin gene reg~ tin~ ~rote~ll, atrial natnuretic protein colony stim~ ting factor, betaseron, erythropoietin (EPO), interferons such as a, b or g interferon, somatropin, somatotropin, somatostatin, insulin-like growth factor (som~tome~lins), l~uLei~ ;.lg hormone release 20 hormone (LHRH), tissue pl~minogen activator (TPA), ~,rovvll~
hormone releasing hormone (GHRH), oxytocin, estradiol, growth hormones, leuprolide acetate, factor VIII, interleukins such as interleukin-2, and analogues thereof; analgesics such as fentanyl, sufentanil, butorphanol, I,~l~r~llorphine, levorphanol, morphine, 25 hydromorphone, hydrocodone, oxymorphone, methodone, lidocaine, bupiv~ine, diclo~enac, naproxen, paverin, and analogues thereof;
anti-migraine agents such as sumal~ , ergot aLI~aloids, and analogues thereof; anti-coagulant agents such as heparin, hirudin, and analogues thereof; anti-emetic agents such as scopol~mint-, ondanesetron, 30 domperidone, metoclopramide, and analogues thereof; cardiovascular agents, anti-hypertensive agents and vasodilators such as ~lilti~7~m, clonidine, nifedipine, verapamil, isosorbide-S-mononitrate, organic nitrates, agents used in the tre~tm~o~t of heart disorders, and analogues thereo~; sedatives such as benzodiazepines, phenothiozines, and WO 97/21457 PCT/IE~)6/~

analogues thereof; narcotic antagonists such as naltrexone, naloxone, and analogues thereof; rh~ tin~ agents such as defero~min~, and analogues thereof; anti-diuretic agents such as desmopressin, vasopressin, and analogues thereof; anti-~n~in~l agents such as S nitroglycerine, and analogues thereof; anti-neoplastics such as 5-fluorouracil, bleomycin, and analogues thereof; prost~ n~in~ and analogues thereof; chemotherapy agents such as vincristine, and analogues thereof; and ~nti~e~n~e oligonucleotides.

Brief Description of the Drawings The invention will now be further described by the following descriptions of embodiment thereof, given by way of exarnple only, with reference to the acco~ ying Drawings, in which:

Fig. 1 is a sectional elevation of a cartridge-based drug delivery device according to the invention, before use;

1S Fig. 2 is a section elevation of the device of Fig. 1, in use;

Fig. 3 is a perspective view of the device as illustrated in Fig.
l;

Fig. 4 is a sectional elevation of a second embo~lime~t of a device according to the invenliion, before use;

Fig. S is a perspective view of the device of Fig. 4;

Fig. 6 is a sectional elevation of a third embo~limeIlt of a device according to the invenltion, before use;

Fig. 7 is a sectional elevation showing the device of Fig. 6 ~ when it has been primed and is ready for use;

2S Fig. 8 is a sectional elevation of the device of Figs. 6 and 7, when delivery has been completed;

Figs. 9-11 are perspective views of the device as illustrated in ~igs. 6-8, respectively;

Fig. 12 is a section elevation of an alternative expelling means for use in a device according to the invention;

s Figs. 13-15 are schPm~tic representations of a fourth embocliment of the device in successive stages of being applied to the skin of a subject;

Fig. 16 is a sectional elevation of a fifth embo~limPnt of a device according to ~e invention, illustrated before use;

Fig. 17 is a sectional elevation of the device of Fig. 16, when delivery has almost been completed;

Fig. 18 is a cross-sectional elevation of the device of Fig. 17, taken along the line A-A;

Fig. 19 is an enlarged view of a detail of Fig. 18;

Fig. 20 illustrates the device of Figs. 16-19, after use; and Fig. 21 is a sr-hem~tic represent~tion of a sixth emboclirn~ t of a device according to the invention.

Modes for Carrying Out the ~vention In Fig. 1 there is indicated, generally at 10, a cartridge-based 20 drug delivery device according to the invention. Device 10 is in the form of a body 11 comprising a cartridge 12 and a m~mber 13 defilliug a skin contacting surface 14. Surface 14 is covered by a release liner 15 before use.

A piston 16 is con~inefl in cartridge 12 and defines on one side 25 thereof a drug compar~nent 17 and on the other side thereof a driving WO 97/21457 PCT/IE96/'~O~Y';

cl1~m~er 18. Compartment 17 is filled with a liquid drug and is sealed at the end opposite piston 16 by a stopper 19. A needle ~.csemhly 20 is mounted on cartridge 12. Needle ~sçmbly 20 has a hollow delivery nee~ 21 extentlin~ thelerlulll, and delivery nee~ 21 is provided with s co.. --~.. ic~tion means in the form of a conduit nee~le 22. As illustrated in Fig. 1, conduit n~e~ 22 penetrates into but not through stopper 19 before use.

A spring 23 is held under conl~icssed tension by a rod 24 having a plate 25 at one end thereof and a catch pr~jection 26 at the o~er end thereof. Rod 24 extends through an orifice 26a in a wall section 27 and catch projection 26 is retained by wall section 27 such that spring 23 is held under tension as long as catch projection 26 rem~in~ in position.
Plate 25 abuts against piston 16.

Cartridge 12 is connected to member 13 by means of a living hinge 28. A simple snap mech~ni~m (not shown) causes device 10 to remain in the configuration illustrated in Fig. 1 until cartridge 12 and member 13 are compressed together giving rise to the working configuration illustrated in Pig. 2. An aperture 29 in skin-contacting surface 14 allows nee~ 21 to proJect dlerethrough, thereby permittin~
cartridge 12 and member 13 to be pressed together such that, in use, cartridge 12 lies subst~nti~lly flat ~g~inst skim-con~cting surface 14.

The operation of the device can be explained as follows. Before use, the device is in the configuration shown in Fig. 1. Fig. 3 shows a perspective view of device 10 in the same configuration, in which body 2s 11, cartridge 12, member 13, release liner lS, piston 16, needle assembly 20 and aperture 29 can be seen. ~mme~i~tely before use, release liner 15 is peeled away from skin-contacting surface 14, and - skin contacting surface 14 is ~hen placed against the skin to which it adheres by means of an adhesive coating. Downward pressure is then ~ 30 exerted on the upper surface 30 (see Fig. 3) of body l l c~ in,~
cartridge 12 to be snapped towards mPmber 13 by means of hinge 28 and the snap m~rh~ni.sm (not shown~. Delivery needle 21 passes through aperture 29 and penetrates ~rough the skin.

It can be seen in Fig. 1 that catch projectis)n 26 rests ~in~t an ablltment 31 before use. Referring to Fig. 2, it can be seen that when cartridge 12 has been snapped towards skin co~cting s~ ce 14, wall section 27 moves relative to ablltm~nt 31. Bec~l~se wall section 27 5 moves downwards and catch projection 26 is prevented from moving downwards by ab~ nt 31, the relative moverr~ents of wall section 27 and catch projection 26 cause catch projection 26 to be dislodged enabling it to pass through orifice 26a in wall section 27, which it does readily as spring 23 is under co~ ssed tension. Once catch projection 26 is released, spring 23 urges rod 24 to move towards the position shown in Fig. 2.

This movement of rod 24 causes plate 25 to push piston 16 so as to compress drug compartment 17. As the liquid filling compartment 17 is incompressible, the pressure is transmitted to stopper 19 which 15 moves towards n~e~ assembly 20 such that conduit needle 22 penetrates completely through stopper 19, thereby effecting co~ lllic~tion between compar~nent 17 and delivery needle 21. This creates an outlet from conl~a~ ent 17 (namely via the delivery neeAle 21 into the skin, subcutaneous tissue or cardiovascular system of the 20 subject to whom the drug is being delivered), thereby permittin~ piston 16 to continue to move forward under the urging of spring 23 (via plate 25), which causes the contraction of compartrnent 17 and the ejection of the liquid drug therefrom. Piston 16 moves forward until it meets stopper 19, at which point the reservoir is effectively empty and 2~ the device can be removed from the skin.

Removal of the device from the skin merely involves pulling body 11 upwards to remove delivery needle 21 from the skin, and peeling skin cont~cting surface 14 away from the skin. The use of a snap mech~ni~m means that cartridge 12 and m~her 13 disengage 30 from one another (i.e. body 11 snaps back to its original configuration as illustrated in Figs. 1 and 3) before skin contacting surface 14 is peeled off the skin. This ~ çn~ement has the result that when removed, device 10 is harmless bec~llse delivery needle 21 has been WO 97/214S7 PCT/IE~)6~1~C-'5 retracted through aperture 29 and is thereby concealed, preventing accidental injury and poss;ble risk of infection from delivery nee~ . 21.

While the description of operation given above details the oyer~lion of the me~h~ni~m at some length, the actual operation from the patient's point of view is as follows. Firstly, the release ~iner is peeled away to reveal a sterile adhesive sllrface. Secondly, the device is pressed ~in~t the skin by applying pressure to top surface 30. Th;s act causes (i) the adhesion of skin coT-t~çting surface 14, (ii) the snapping together of cartridge 12 and member 13, (iii) the resulting 10 dislodgement of catch pro~ection 26, which leads to (iv) the penetration of stopper 19 by conduit needle 22 and (v) the delivery of the coll~enls of compartment 17 through delivery needle 21. After delivery, body 11 is lifted away from the skin. This act causes the retraction of needle 21, thereby m~kin~; the device safe for disposal.

All the patient has to do, therefore, is: (a) peel away the release liner, (b) press the device against the skin, and (c) lift the device off the skin when delivery has been completed. Tlhe completion of delivery can be observed by monitoring the movement of piston 16 along the length of cartridge 12 (see Fig. 3).

All of the steps relating to correctly ~lmini.~tering a precise dosage of drug are accomplished by the single step (b), namely applying pressure to upper surface 30. This simplicity opens up the possibility of self ~timini.~tration by patients who would be unable or unwilling to self ~tlmini.~ter a drug otherwise. The configuration of 2s device 10 not only ensures that the entire m~.ch~ni.~m is activated by a single step, but it also compels the patient to ~imini.cter the drug correctly. The m~ch~ni~m causes delivery needle 21 to penetrate the skin at the correct angle and to the correct depth, and since cartridge 12 is prefilled with a known volume of drug, the metering of the dose to be delivered is automatic and is removed from the patient's responsibility.

WO 97/21457 PCT/IE96/~ Ja -Furthermore, while other drug delivery devices are known which can be applied to dle skin such that a neeA1~ correctly penetrates the skin and such that the drug is delivered upon application of the device, the structure and mode of operation of ~e device shown in 5 Figs. 1-3 is much simpler ~an for l~nown devices. ~nllf~et~lring costs are si nific~ntly lowered, and dle risks of malfunction or p~ti~nt error are clearly reduced by simplifying the construction and operation of ~e device.

A further advantage provided by the device of Figs. 1-3 is that 10 from the p~ti~nt's point of view, the needle is invisible. This is a distinct advantage for subjects who are uncomfortable with ~e idea of injections and needles. The ~ meter of the needle used in the embo~1im~nt of Figs. 1-3 is 0.25 mm, m~kin~ it sufficiently small that it is effectively painless when it penetrates the skin. 'rhe internal 15 ~ meter is nevertheless big enough to allow the delivery of macro-molecular compounds such as peptides, polypeptides and proteins.
Although device 10 as shown in Figs. 1-3 does not entirely conceal delivery neeflle 21 (which can be seen by looking into the gap between member 13 and cartridge 12), a collar can be provided around the 20 periphery of skin contacting surface 14 so as to conceal the needle at all times, if the visibility of the needle is a major concern.

Refel.hlg now to Fig. 4, there is indicated, generally at 40, a different embodiment of a drug delivery device according to the invention. Device 40 is in many respects simil~r to device 10 of Figs.
2s 1-3, but a dir~lc~-~ expelling means is employed and a different mech~ni~m for actll~tin~ the expelling means is employed. In device 40, piston 41 is driven by gas pressure. Gas is generated by the reaction of a ~uantity of citric acid solution 42 with a sodium bicarbonate tablet 43. In Fig. 4, device 40 is illustrated before use (a 30 perspective view can be seen in Pig. 5). Citric acid solution 42 is cont~ine-l within a compartment defined by a lu~ulable membrane 44.
A solid n~edle 45 is disposed with its point imme~ t~ly adjacent to membrane 44. Needle 45 projects from a wishbone structure 46 through a stopper 47. Stopper 47 and piston 41 form a sea~ed compartment such that the generation of gas causes piston 41 to move in the direction indicated by the arrow.

The gas generator 42,43,44 is ~chl~ed by pressing ~e cartridge 48 and member 49 (which ~le-fin~s a skin-cont~ctin~ s~ ce S0) s together. In practice this is done by placing surface S0 against the skin and pressing downwards on upper s -rf~ce Sl (see Fig. 5). When cartridge 48 and member 49 are pressed together (via the flexing of a hinge 52) a pair of brackets 53 supporting wishbone structure 46 also approach one another. Wishbone structure 46 is flexible, so the lO movement of the brackets 53 causes wishbone structure 46 to flex, thereby moving needle 45 in the direction intli~te~l by the arrow. This movement ruptures membrane 44, thereby releasing citric acid 42 which contacts sodium bicarbonate 43 and generates a gas to provide a driving force equivalent to spring 23 of device 10 illustrated in Figs. 1-lS 3.

Referring now to Figs. 6-11, one can see a further embo-lim~nt of the invention. Figs. 6, 7 and 8 illustrate the device in sectional elevation, and Figs. 9, 10 and 11 are perspective views of the device as illustrated in Figs. 6, 7 and 8, respectively.

Referring first to Fig. 6, the device, in~lic~ted generally at 60 has many featllres in common with the devices previously described. In particular, there is a cartridge 61 connecte~l by a hinge 62 to a mPmber 63 defining an adhesive skin-cont~cting surface 64. A piston 65 ~lefin~s a drug compartment 66 which is sea~ed by a stopper 67.

A nPe-llç ~sçmbly 68 is moveable wi~ respect to cartridge 61 in the direction indicated by the arrow so as to pierce slo~pel 67 and - thereby provide commllnication between drug compartment 66 and a delivery needle 69, as illustrated in Fig. 7.

Pressure in the direction indicated by the arrow also causes 3û cartridge 61 to move relative to a mounting member 70 on which cartridge 61 is slidably mounted. Member 70 is provided with WO 97/21457 PCT/IES'I;

penetrating means 71. When cartridge 61 moves in the direction indicated by the arrow relative to member 70, penetrating means 71 pierces a compar~nent 72 to release a quantity of water.

Referring to Fig. 7, it can be seen that a perforated polyethylene 5 bellows 73 is wetted by the water retP~e!1 from co~ a~ ent 72.
Bellows 73 is water permeable and is filled with a gel which swells in the presence of water, such as acrylite gels. The choice of gel material determines to a large extent the rate of delivery. The delivery rate is also affected by the permeability of the bellows. The permeability of lQ the bellows may be deterrnin~l by the number and size of perforations or by the nature of the matenal (which may be water permeable) used for the bellows.

When nee~lle ~ssembly 68 has been pushed back to the extent in~lic~ted in Figs. 7 and 10, the device is primed, at which point the 15 release liner 74 is peeled away, skin-cont~ctin~ surface 64 is pressed against the skin, and then pressure is applied to upper surface 75 (Figs.
8 and 11) such that delivery needle 69 emerges through aperture 76 and penetrates the skin of the subject. De~ivery is effected by the expansion of bellows 73 (when wetted) to drive piston 65 (see Fig. 8).

The device of Figs. 6-11 is not shown to scale as the degree of exr~n~ion shown in Fig. 8 would not be achieved by a bellows and water compar~nent of the size shown in Figs. 6 and 7. However, the principle of a permeable, gel-filled bellows expanding as water is absorbed by the gel is clear.

A freely permeable barrier 77 is provided between mounting member 70 and bellows 73. Barrier 77 is fixed relative to the cartridge, and so when compartrnent 72 is pierced and bellows 73 begins to expand as it absorbs water, barrier 77 prevents bellows 73 from exp~n-ling backwards into the space formerly occupied by the water in compartrnent 72. Although cartridge 61 is firmly mounted on mounting member 70, the seal between cartridge 61 and mounting member 70 is vacuum tied. A small amount of le~k~ge is allowed for, WO 97121457 PCT/IE96~ G-to allow air to be drawn into ~e space between mounting m~mher 70 and barrier 77 as the water is drawn out of that space by absorption into bellows 73. The degree of le~k~e is small enough, however, to prevent water from seeping out (this is perfectly possible given the 5 dirrelellces in properties between wat~r and air). As an alternative, a gas-permeable, water imperme~l~le material could be used for mounting member 70 (or a section thereof).

An important difference between ~e devices of Figs. 1-5 on the one hand and the device of Figs. 6-11 on the other hand is that whereas 10 spring 23 (in Figs. 1-3) relaxes rapidly to provide a bolus delivery of drug, and gas generator 42,43,44 (in Figs. 4 and 5), when ~rtll~te~l, generates a gas quickly over a short period of time to give bolus delivery, the swelling gel mech~ni~m of Figs. 6-11 provides a slow continuous expansion. Accordingly, whereas device 10 of Figs. 1-3 1~ and device 40 of Figs. 4 and 5 act as bolus injectors, device 60 of Figs.
6-11 acts as an infusion pump which can be used to deliver drug over a period dictated by the design of the device. It generally delivers all of the drug over an extended period of time, e~uivalent to the delivery provided by an infusion pump (for example, such as over a 12 hour, 24 hour or 48 hour period).

Referring next to Fig. 12, a further expelling means is indicated, generally at 80. Expelling means 80 is again positioned at an end of a cartridge 81. The expelling means 80 consists essentially of a fixed end cap 82 and a moveable end cap 83 which is slidable within cartridge 81 2s and which serves as a piston to coll~p~ss drug compartment 84.
Between them, the end caps 82,83 define a driving chamber which is filled wi~ a swellable gel 85. A flexible perforated spiral wound plastics tube 86 also extends within the space defined by the end caps 82,83, and tube 86 is in commllnic~tion, in use, with a source of water (not shown) via an inlet 87 in end cap 82. When water enters tube 86, ~ it is free to enter gel 85 via perforation in tube 86. Gel 85 expands when it absorbs the water and because gel 85 co.~ les to absorb water as it expands, water is contin-~lly drawn in via inlet 87. The exp~nsion of gel 85 causes end cap 83 to slide within the interior of cartridge 81 7 PCT/IE~)G~

~ereby compressing drug compa~ ent 84 and ejecting a liquid drug cont~ine(l therein through an outlet, as described in relation to previous embo~lim~nt~.

Figs. 13-lS illustrate a sch~m~tic diagram of a further s embo-limP!nt of the invention. It will be noted that the device in~ te generally at 90 has many features in common with devices previously described. In particular, there is a cartridge 91 slidably mounted on a mounting member 92 provided with penet~tin~ means 93. A piston 94 defines a drug co~ alllllent 9S on one side thereof and a driving lo ch~mber 96 on the other side thereof . Driving chamber 96 contains a tulable citric acid compartment 97 and a sodium bicarbonate tablet 98 such that when compartment 97 is penetrated by penetrating means 93, citric acid is released to sodium bicarbonate tablet 98 in order to generate a gas and drive piston 94 along cartridge 91.

The end of drug compartrnent 95 opposite piston 94 is sealed by a penetrable stopper 99. A n~e~lle ~sçmbly 100 which has a hollow conduit needle 101 extending at right angles from a hollow delivery needle 102 is mounted on cartridge 91 such that movement of needle assembly lO0 in the direction in-lis~t~l by ~e arrow causes conduit needle 101 to pierce stopper 99, thereby establishin~ commlmiç~tion between drug compartment 95 and delivery needle 102.

Mounting member 92 is conn~cted by a hinge to a base member 103 which defines a skin-cont~ctin~ surface 104. Base member 103 is provided with a lever mounting 105 on which a lever 106 is pivotally 2s mounted. Actuation of lever 106 in the direction indicated by the arrow in Fig. 13 causes the device to assume the configurations shown in Fig. 14 (initi~lly) and Fig. lS (subsequently). Actuation of lever 106 pushes needle assembly 100 (to which lever 106 is pivotally mounted by means of a pivot 107) onto cartridge 91, and pushes cartridge 91 onto mo~nting member 92. This causes (a) the penetration of stopper 99 by conduit nee~lle 101 and (b) the penetration of citric acid compartment 97 by penetrating means 93. As indic~terl in relation to previous embodiments, this has the effect of establi~hing WO 97/21457 PCT/IE96~D

commllnicat;on between drug compartment 95 and delivery needle 102 and also of initi:~ti"~ the generation of gas which will drive piston 94 to expel the liquid drug from drug compartrnent 95.

Co~tinlled ~ctl~tion of lever 106 to the position inr~ ted in Fig.
15 causes n~erll~ 102 to penetrate in~o the sl~in. It will be appreciated that the ~ctll~tion of lever 106 accomplishes the ~e~l~tior~ of the expelling means, the establi~hm~o~t of cornml-ni~tion between the drug compartment 95 and ~e delivery needle 102, and the collecl penetration angle and depth of delivery needle 102 into the skin.
Correct and fail-safe dosing is therefore inevitable.

In Fig. 16 there is indicated, generally at 110 a device similar to that of Fig. 1. Thus, it will be noted that the main components are identical and that the expelling means which drives the piston 111 along cartridge 112 comprises the spring 113 which acts on pusher plate 114 to drive the piston 111. ~3efore use, the spring 113 is held in place by rod 115 and catch projection 116 which extends through an orifice 117 in wall section 118.

As with the device of Fig. 1, when base member 119 is placed on and adheres to the skin and pressure is exerted on top surface 120 of device 110, catch projection 116 moves relative to orifice 117 because catch projection 116 is prevented from moving downwards by ab-ltment 121. Precompressed spring 113 causes catch proJection 116 to move through orifice 117 and exerts a force on piston 111. As previously described in relation to the device of Figs. 1-3, this force 2s causes a stopper 122 to pierce conduit needle 123 and then causes the ejection of drug from the interior of cartridge 112.

Referring initially to Fig. 17, it can be seen that rod 115 is provided with first and second extension members 123, 124. As rod ~ 115 moves from the starting position illustrated in Fig. 16 towards the position illustrated in Fig. 17, catch projection 116 serves to pull first extension member 123 forward and ~is in turn pulls the second extension member 124 forward. The second extension member 124 is WO 97/21457 PCT/IE~6~ C~

provided with a projection 125 which extends through an orifice 126 in ab~ltment 121. Projection 125 and orifice 126 act as a snap meçh~ni~m which is illustrated in greater detail in Figs. 18 and 19. Fig. 18 shows a sectional elevation through the line A-A in Fig. 17. In Fig. 18 s ab -tm~nt 121, projection 125 and orifice 126 can been seen. Fig. 19 shows projection 125 and orifice 126 in greater detail. It can be seen that orifice 126 is provided with a pair of resilient teeth 127. These teeth allow projection 125 to move from the initial position as shown in Fig. 16 (and indicated in dotted outline in Fig. 19 by lt;ft;rc~ce numeral 125'~ to the working position shown in Fig. 17 (indicated by ~efelellce numeral 125 in Fig. 19). VVhen device 110 is applied to the skin and top surface 120 is pressed downwards, projection 125 snaps from position 125' to the position shown in Fig. 19. A spring 128 (see Figs.
16 and 17) resists this downward movem~nt However, once projection 125 has snapped downwards, resilient teeth 127 prevent projection 125 from moving back up under the urging of spring 128.

If one refers to Fig. 20, it can be seen that when piston 111 moves to its final position, catch projection 116 pulls first extension member 123 and second extension member 124 forwards to a sufficient extent that projection 125 is pulled forward and dislodged from orifice 126. This disengages the snap mech~ni~m and allows cartridge 112 to move away from base member 119 under the influence of spring 128, to the position illustrated in Fig. 20. This has the effect of d;seng~ing the delivery needle 129 from the skin and retracting it to a safe position. Additionally, it has the effect of indicating to the subject that delivery is completed. In use, therefore, the subject would apply device 110 to ~e skin, press downwards on the top surface 12() to begin delivery and shortly afterwards, top surface 120 would spring up indicating that delivery had been completed.

The same or a simil~r snap meçh~ni~m could be used with many of the other embodiments previously illustrated, as will be apparent to the skilled person.

WO 97/21457 PCT/IE~ S--~

In Fig. 21 there is indicated, generally at 130, a sçh~ t;c illustration of a device according to ~he invention. Device 130 is designed to be used in cases where a relatively long n~e~ is required (more specifically where there is a high ratio of nee~lle length to 5 distance from hinge to penetration point. For example, Fig. 21 shows a device being llsed for intr~mllsc~ r injections, and accordingly it employs a long delivery needle 131.

Delivery needle 131 must be sufficiently long to penetrate through the skin 132, fat 133 and into mllsele 134 when base section 135 is applied to a subject and top surface 136 is pushed downwards so as to cause the penetration of the skin and the actuation of the expelling means. The actual operation of the device can be the same as any of the devices previously illustrated, or can be a variant on these emboclimçns~

lS The important point to note about device 130 is that the length of needle 131 (exaggerated) causes its own problems. If needle 131 was straight, the point 137 thereof would pierce the skin and then as cartridge 138 approached base section 135, the rem~in~ler of the needle would follow the point into the skin. However, as well as entering the 20 skin vertically (i.e. normal to the surface of the skin), the hinge mech~ni~m gives the needle's movement a lateral component (i.e.
parallel to the surface of the skin). For a long needle or a relatively small device, this lateral movement of the needle between the position in which the point penetrates the surface of the skin and the position in 2~; which the needle is fully embedded can be subst~nti~l Tncte~l of creating a single entry point, the needle causes the skin to stretch or tear during penetration and retraction of the needle. However, needle 131 of device 130 is provided with a curvature such that it lies along an arc of an im~gin~ry circle 139. The centre of circle 139 is at hinge 140, and the radius or of circle 139 is equal to the ~list~nce between hinge 140 and needle 131. This cun~ature means that when needle 131 enters the skin, it does so at a single point and the entire needle enters the skin at the point where tip 137 penetrates the surface of the skin.
The application of device 130 is therefore far less tr~llm~tic than would WO 97/21457 PCTfIE96/00085 , .
be ~e case for a device having a straight n~e~lle, and after removal, the skin and underlying tissue is less ~l~m~ed than would otherwise be the case.

This type of curved needle is not just required for i~ sc~ r 5 injections as even subc.~ eous injections may require a de~ivery neetll~.
of up to 10 mm in length (~lepe-ndin~ on ~e site to which the device is being applied.

Of course, it might be ~ought that the lateral movement of the nee~lle could be reduced to a negligible amount by providing the needle 10 closer to the hinge, and this is undoubtedly true. However, it has been found that it is advantageous to locate the needle at a point distal from the hinge as this means that when the cartridge moves towards the base member (particularly when a snap meçh~ni~m is provided) the velocity of the nee~le into the skin is much higher and the application of the 15 device is, as a result, less painful.

Another reason why the n~e-lle cannot simply be placed close to the hinge in order to overcome the problems associated with lateral movement during penetration is because this places constraints on the angle of rotation between the cartridge and the skin contacting surface 20 (e.g. in moving from the configuration of Fig. 1 to the configuration of Fig. 2). Conversely, when the needle is positioned adjacent to the hinge point, even a relatively large angle of rotation gives a limited penetration depth. For reasons of compactness during storage and transit, it is usu~lly preferred to keep the open angle at the hinge to a 25 minimllm, i.e. to keep the device as flat as possible.

As an aid to compliance for children, the device can be provided with a housing which will appeal to children and which they will readily apply to their skin (where they would be reluctant to do with a conventional in~ection device).

Claims (37)

Claims:-
1. A liquid drug delivery device comprising a base member defining a skin-contacting surface for application to the skin of a subject, a columnar cartridge serving as reservoir for the drug and which is connected to the base member such that in use the longitudinal axis of the cartridge is disposed substantially parallel to the skin-contacting surface a delivery needle communicating in use with the interior of the cartridge and adapted to penetrate the skin of the subject, and means for expelling a drug out of the interior of the cartridge and through the skin of the subject via the delivery needle.
2. A device according to Claim 1, wherein a portion of the interior of the cartridge defines a drug compartment for the drug, the drug being expelled from the compartment by a piston actuated by the expelling means.
3. A device according to Claim 2, wherein the interior of the cartridge also defines a chamber housing the expelling means, such that the actuation of the piston by the expelling means causes the expansion of said chamber and the contraction of said drug compartment.
4. A device according to Claim 2 or 3, which is provided with a conduit enabling fluid communication to be established in use between the drug compartment and the delivery needle.
5. A device according to Claim 4, wherein the conduit extends at substantially right angles from the delivery needle.
6. A device according to Claim 5, wherein the conduit is integral with the delivery needle.
7. A device according to Claim 5 or 6, wherein the delivery needle and the conduit form part of a needle assembly mounted on an end of the cartridge.
8. A device according to any preceding claim, further comprising a mechanism for actuating the expelling means.
9. A device according to any preceding claim, wherein the connection between the cartridge and the base member allows relative movement therebetween from an initial configuration to a working configuration.
10. A device according to Claim 9, when dependent on Claim 8, wherein said relative movement operates the mechanism for actuating the expelling means.
11. A device according to Claim 9 or 10, wherein said relative movement causes the delivery needle to project through the plane of the skin-contacting surface and thereby penetrate the skin in use.
12. A device according to any one of Claims 9-11, wherein said relative movement causes the establishment of fluid communication between the drug compartment and the delivery needle.
13. A device according to any preceding claim, wherein the connection between the cartridge and the base member is provided by a hinge enabling the cartridge and the base member to be pressed towards one another from a spaced-apart initial configuration to an adjacent working configuration.
14. A device according to any preceding claim, wherein the skin-contacting surface is provided with an aperture through which the delivery needle extends in use.
15. A device according to any preceding claim, when dependent on Claim 5, wherein an end of the cartridge is provided with a stopper and the conduit and stopper are movable relative to one another to allow the conduit to penetrate through the stopper and thereby establish said communication.
16. A device according to Claim 15, wherein the position of the needle assembly is fixed with respect to the cartridge, and the stopper is movable relative to both the cartridge and the needle assembly.
17. A device according to Claim 16, wherein the actuation of the expelling means causes the stopper to be pressed onto and penetrated by the conduit.
18. A device according to Claim 15, wherein the position of the stopper is fixed with respect to the cartridge, and the needle assembly is movable relative to both the cartridge and the stopper.
19. A device according to any preceding claim, wherein the expelling means comprises a pre-compressed spring.
20. A device according to Claim 19, wherein the mechanism for actuating the expelling means comprises a catch which when released enables the pre-compressed spring to relax.
21. A device according to Claim 20, when dependent on Claim 9, wherein said relative movement causes the catch to be released.
22. A device according to any one of Claims 1-18, wherein the expelling means comprises a gas generator which generates a gas when two or more reactants are brought into contact.
23. A device according to Claim 22, wherein the gas generator comprises at least one liquid.
24. A device according to Claim 23, wherein the gas generator comprises the components of an effervescent couple.
25. A device according to any one of Claims 1-18, wherein the expelling means comprises a material which swells in the presence of a liquid, and also comprises a supply of said liquid.
26. A device according to Claim 25, wherein said material is a swellable gel and said liquid is water.
27. A device according to any one of Claims 22-26, when dependent on Claim 9, wherein said liquid is contained within a rupturable compartment and the mechanism for actuating the expelling means comprises a penetrating member, the penetrating member and the rupturable compartment being moved relative to one another upon the relative movement of the cartridge and the base member, so as to cause the penetration of said rupturable compartment and the actuation of the expelling means.
28. A device according to any preceding claim, when dependent on Claim 9, further comprising a snap mechanism which maintains a stable initial configuration and a stable working configuration and which when actuated causes the device to snap from said initial configuration to said working configuration.
29. A device according to Claim 28, further comprising resilient means biasing the device to said initial configuration and means for disengaging said snap mechanism when delivery has been completed.
30. A device according to Claim 28 or 29, when dependent on Claim 2, wherein said disengaging means comprises a member linked to said piston such that when the piston has completed the expulsion of drug from the drug compartment, said member is caused to move and said movement causes the disengagement of said snap mechanism, such that said resilient means causes the device to resume said initial configuration.
31. A device according to any preceding claim, when dependent on Claim 11, wherein said relative movement is a pivotal movement.
32. A device according to Claim 31, wherein the cartridge and base member are connected by means of a hinge.
33. A device according to Claim 32, wherein said delivery needle projects through the plane of the skin-contacting surface at or outside of the periphery of the skin-contacting surface.
34. A device according to Claim 32 or 33, wherein the delivery needle is in the shape of a segment of arc of an imaginary circle, said circle having a radius equal to the distance between the delivery needle and the hinge and lying in a plane which is substantially normal to the plane of the skin-contacting surface.
35. A device according to any one of Claims 1-33, wherein the delivery needle is straight.
36. A device substantially as herein described with reference to and as illustrated by Figs. 1-3, Figs. 4 and 5, Figs. 6-11, Fig. 12 or Fig.
13-15 of the accompanying drawings.
37 . A drug cartridge assembly comprising:
a cartridge for containing drug, the cartridge having a first end and a second end;

a piston slidably engaged at the first end of the cartridge, the piston in communication with means for expelling the drug from the cartridge; and a delivery needle assembly fixed to the second end of the cartridge, the delivery needle assembly comprising a delivery needle and a conduit enabling communication to be established during use between the drug compartment and the delivery needle.
CA002238614A 1995-12-11 1996-12-11 Cartridge-based drug delivery device Abandoned CA2238614A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US849995P 1995-12-11 1995-12-11
US60/008,499 1995-12-11

Publications (1)

Publication Number Publication Date
CA2238614A1 true CA2238614A1 (en) 1997-06-19

Family

ID=21731948

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002238614A Abandoned CA2238614A1 (en) 1995-12-11 1996-12-11 Cartridge-based drug delivery device

Country Status (11)

Country Link
US (1) US5858001A (en)
EP (1) EP0902696B1 (en)
JP (1) JP2000515394A (en)
AT (1) ATE214954T1 (en)
AU (1) AU1808797A (en)
CA (1) CA2238614A1 (en)
DE (1) DE69620257T2 (en)
IL (1) IL124470A0 (en)
TW (1) TW317503B (en)
WO (1) WO1997021457A1 (en)
ZA (1) ZA9610374B (en)

Families Citing this family (531)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221056B1 (en) * 1996-12-20 2001-04-24 David G. Silverman Strong diaphragm/safe needle units and components for transfer of fluids
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
JP2002505601A (en) 1997-06-16 2002-02-19 エラン コーポレーション ピーエルシー Pre-filled drug delivery device and method of making and assembling the same
US6500150B1 (en) * 1997-06-16 2002-12-31 Elan Pharma International Limited Pre-filled drug-delivery device and method of manufacture and assembly of same
IE970782A1 (en) 1997-10-22 1999-05-05 Elan Corp An improved automatic syringe
CA2325004A1 (en) 1998-03-23 1999-09-30 Ehoud Carmel Drug delivery device
US6126637A (en) * 1998-04-15 2000-10-03 Science Incorporated Fluid delivery device with collapsible needle cover
US6355021B1 (en) * 1998-07-14 2002-03-12 Maersk Medical A/S Medical puncturing device
US6428528B2 (en) 1998-08-11 2002-08-06 Antares Pharma, Inc. Needle assisted jet injector
CA2350706A1 (en) 1998-11-13 2000-05-25 Elan Pharma International Limited Drug delivery systems and methods
US6406455B1 (en) * 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US6461331B1 (en) 1999-05-21 2002-10-08 Minimed Inc. Device and method for infusion of small molecule insulin mimetic materials
US6464628B1 (en) 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
US6482145B1 (en) 2000-02-14 2002-11-19 Obtech Medical Ag Hydraulic anal incontinence treatment
US6471635B1 (en) 2000-02-10 2002-10-29 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
US6461292B1 (en) 1999-08-12 2002-10-08 Obtech Medical Ag Anal incontinence treatment with wireless energy supply
EP1220697B1 (en) 1999-10-11 2004-12-29 Felton International, Inc. Universal anti-infectious protector for needleless injectors
US7074210B2 (en) * 1999-10-11 2006-07-11 Felton International, Inc. Universal protector cap with auto-disable features for needle-free injectors
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
US6391003B1 (en) 1999-10-25 2002-05-21 Antares Pharma, Inc. Locking mechanism for a jet injector
US6770054B1 (en) 1999-11-23 2004-08-03 Felton International, Inc. Injector assembly with driving means and locking means
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
WO2001051109A1 (en) * 2000-01-07 2001-07-19 Biovalve Technologies, Inc. Injection device
DE60110747T2 (en) * 2000-02-10 2006-02-23 Potencia Medical Ag MECHANICAL DEVICE FOR IMPOTENCE TREATMENT
DE60113377T2 (en) * 2000-02-10 2006-06-14 Potencia Medical Ag CONTROLLED HARNINE INCONTINENCE TREATMENT
MXPA02007649A (en) 2000-02-10 2004-08-23 Potencia Medical Ag Urinary incontinence treatment with wireless energy supply.
US20030125768A1 (en) * 2000-02-11 2003-07-03 Forsell Peter Impotence treatment apparatus with energy transforming means
ATE380006T1 (en) * 2000-02-11 2007-12-15 Potencia Medical Ag CONTROLLED IMPOTENCY TREATMENT
DE60111019T2 (en) 2000-02-14 2006-05-11 Potencia Medical Ag PROSTHESIS
US20030100929A1 (en) 2000-02-14 2003-05-29 Peter Forsell Controlled penile prosthesis
CA2397284C (en) * 2000-02-14 2010-05-18 Potencia Medical Ag Male impotence prosthesis apparatus with wireless energy supply
IL137431A0 (en) 2000-07-20 2001-07-24 Slo Flo Ltd A new slow release device for controlled delivery of liquid material
US6572586B1 (en) 2000-07-25 2003-06-03 Animas Corporation Low profile infusion set
US6719721B1 (en) * 2000-10-23 2004-04-13 Elizabeth Okazaki Safety port needle assembly
US7150409B2 (en) * 2000-11-30 2006-12-19 Biovalve Technologies, Inc. Injection systems
US6579267B2 (en) * 2001-01-05 2003-06-17 Applied Diabetes Research, Inc. Pivoting joint infusion assembly
US8343115B2 (en) * 2001-01-05 2013-01-01 Applied Diabetes Research, Inc. Low profile pivoting joint infusion assembly
US7083597B2 (en) * 2001-01-05 2006-08-01 Applied Diabetes Research, Inc. Pivoting joint infusion system with seal
US6982264B2 (en) * 2001-06-27 2006-01-03 Elan Pharmaceuticals, Inc. Substituted alcohols useful in treatment of Alzheimer's disease
DE10142418A1 (en) 2001-08-31 2003-04-03 Molecular And Clinical Drug Re drug
US20030088238A1 (en) * 2001-09-26 2003-05-08 Poulsen Jens Ulrik Modular drug delivery system
US20060122577A1 (en) * 2001-09-26 2006-06-08 Poulsen Jens U Modular drug delivery system
US6830562B2 (en) * 2001-09-27 2004-12-14 Unomedical A/S Injector device for placing a subcutaneous infusion set
US6613015B2 (en) * 2001-10-04 2003-09-02 Deltec, Inc. Right angle safety needle
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
US20040078028A1 (en) * 2001-11-09 2004-04-22 Flaherty J. Christopher Plunger assembly for patient infusion device
US7407490B2 (en) 2001-11-29 2008-08-05 Novo Nordisk A/S Delivery device and cartridge therefore
US20030109827A1 (en) * 2001-12-07 2003-06-12 Elan Pharma International Limited Drug delivery system and method
ITTO20011228A1 (en) * 2001-12-28 2003-06-28 Cane Srl DISPOSABLE NEEDLE CONTAINER.
ATE409057T1 (en) 2002-02-11 2008-10-15 Antares Pharma Inc INTRADERMAL INJECTION DEVICE
AU2003208296A1 (en) * 2002-02-12 2003-09-04 Unomedial A/S Infusion device with needle shield
DE10206910A1 (en) * 2002-02-19 2003-09-04 Disetronic Licensing Ag Device for administering an injectable product
MXPA04008660A (en) 2002-03-08 2005-06-08 Applied Diabetes Res Inc Low profile, pivotal connection infusion assembly.
ES2673480T3 (en) 2002-03-26 2018-06-22 Becton, Dickinson And Company Multi-stage fluid supply device and method
US20030195609A1 (en) * 2002-04-10 2003-10-16 Scimed Life Systems, Inc. Hybrid stent
JP4764626B2 (en) 2002-05-06 2011-09-07 ベクトン・ディキンソン・アンド・カンパニー Method and device for controlling the pharmacokinetics of a drug
US6723072B2 (en) * 2002-06-06 2004-04-20 Insulet Corporation Plunger assembly for patient infusion device
CA2493728C (en) * 2002-07-22 2013-10-29 Becton, Dickinson And Company Patch-like infusion device
JP2005533545A (en) 2002-07-24 2005-11-10 エム2・メディカル・アクティーゼルスカブ Infusion pump system, infusion pump unit, infusion pump
US20040059316A1 (en) * 2002-07-31 2004-03-25 Smedegaard Jorgen K. Medical delivery device
EP1386626A1 (en) 2002-07-31 2004-02-04 Novo Nordisk A/S Delivery device for treatment of diabetes mellitus
US20040051019A1 (en) 2002-09-02 2004-03-18 Mogensen Lasse Wesseltoft Apparatus for and a method of adjusting the length of an infusion tube
DK1556124T3 (en) * 2002-09-02 2008-02-18 Unomedical As Apparatus and method for adjusting the length of an infusion tube
US7637891B2 (en) * 2002-09-12 2009-12-29 Children's Hospital Medical Center Method and device for painless injection of medication
WO2004030726A1 (en) * 2002-10-07 2004-04-15 Novo Nordisk A/S Needle device comprising a plurality of needles
US20050075670A1 (en) * 2002-10-07 2005-04-07 Henrik Bengtsson Signal device with electro-muscle stimulation feature
US7014625B2 (en) * 2002-10-07 2006-03-21 Novo Nordick A/S Needle insertion device
US7727181B2 (en) 2002-10-09 2010-06-01 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
WO2004041330A2 (en) * 2002-11-05 2004-05-21 M 2 Medical A/S A disposable wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
US7381184B2 (en) * 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US6896666B2 (en) * 2002-11-08 2005-05-24 Kochamba Family Trust Cutaneous injection delivery under suction
US20060264926A1 (en) * 2002-11-08 2006-11-23 Kochamba Gary S Cutaneous stabilization by vacuum for delivery of micro-needle array
DK200201823A (en) * 2002-11-26 2004-05-27 Maersk Medical As Connection piece for a hose connection
CN1738656A (en) 2002-12-23 2006-02-22 M2医药有限公司 Disposable, wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device
US7252651B2 (en) * 2003-01-07 2007-08-07 Becton, Dickinson And Company Disposable injection device
DE10300896A1 (en) 2003-01-13 2004-07-22 Disetronic Licensing Ag Automatic delivery device driven by hydrogels with adjustable delivery characteristics to deliver a medium, especially insulin
IL154243A0 (en) * 2003-02-02 2003-09-17 Silex Projectors Ltd Stable infusion device
US20040158202A1 (en) * 2003-02-12 2004-08-12 Soren Jensen Cover
US20060069382A1 (en) * 2003-04-11 2006-03-30 Novo Nordisk A/S Delivery device
EP1624915A1 (en) 2003-04-11 2006-02-15 Novo Nordisk A/S Delivery device
ES2737835T3 (en) 2003-04-23 2020-01-16 Valeritas Inc Hydraulically driven pump for long-term medication administration
US7679407B2 (en) * 2003-04-28 2010-03-16 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
TWI272948B (en) * 2003-05-01 2007-02-11 Ares Trading Sa HSA-free stabilized interferon liquid formulations
EP1475113A1 (en) * 2003-05-08 2004-11-10 Novo Nordisk A/S External needle inserter
ATE392223T1 (en) * 2003-05-08 2008-05-15 Novo Nordisk As INTERNAL NEEDLE INTRODUCER
CN100574819C (en) * 2003-05-08 2009-12-30 诺沃挪第克公司 Pivotable needle unit
ATE474611T1 (en) * 2003-05-08 2010-08-15 Novo Nordisk As AN INJECTION DEVICE THAT CAN BE APPLIED TO THE SKIN WITH A SEPARABLE ACTUATING PART FOR INSERTING THE NEEDLE
EP1495775A1 (en) * 2003-07-08 2005-01-12 Novo Nordisk A/S Portable drug delivery device having an encapsulated needle
ATE357939T1 (en) * 2003-07-08 2007-04-15 Novo Nordisk As PORTABLE MEDICINE DELIVERY DEVICE HAVING AN ENCAPSULATED NEEDLE
EP1502613A1 (en) * 2003-08-01 2005-02-02 Novo Nordisk A/S Needle device with retraction means
US8444604B2 (en) 2003-08-12 2013-05-21 Becton, Dickinson And Company Patch-like infusion device
US7766902B2 (en) * 2003-08-13 2010-08-03 Wisconsin Alumni Research Foundation Microfluidic device for drug delivery
CA2536681C (en) 2003-08-28 2011-07-05 Becton, Dickinson And Company Intradermal injection device
KR20060099520A (en) * 2003-10-21 2006-09-19 노보 노르디스크 에이/에스 Medical skin mountable device
CA2543545A1 (en) 2003-10-21 2005-05-06 Ole Christian Nielsen Medical injection device mountable to the skin
EP1527792A1 (en) 2003-10-27 2005-05-04 Novo Nordisk A/S Medical injection device mountable to the skin
PL1682203T3 (en) 2003-10-23 2010-06-30 Novo Nordisk As Medical injection device mountable to the skin
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US7299082B2 (en) * 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
ES2374530T3 (en) * 2003-12-11 2012-02-17 Ares Trading S.A. STABILIZED INTERFER LIQUID FORMULATIONS.
US7896841B2 (en) * 2004-02-17 2011-03-01 Children's Hospital Medical Center Injection device for administering a vaccine
DK1727576T3 (en) * 2004-03-26 2009-07-06 Unomedical As Infusion
CN100586495C (en) * 2004-03-30 2010-02-03 诺和诺德公司 Actuator system comprising lever mechanism
CN1938061B (en) * 2004-03-30 2010-10-06 诺和诺德公司 Actuator system comprising detector means
DK1732627T3 (en) 2004-03-31 2010-08-16 Lilly Co Eli Injection apparatus having a needle cartridge for dispensing a pharmaceutical liquid
US20070135697A1 (en) * 2004-04-19 2007-06-14 Therasense, Inc. Method and apparatus for providing sensor guard for data monitoring and detection systems
US20050240154A1 (en) * 2004-04-21 2005-10-27 Unomedical A/S: Infusion set with patch
EA012205B1 (en) * 2004-05-17 2009-08-28 Арес Трейдинг С.А. Hydrogel interferon formulations
ES2418833T3 (en) 2004-06-01 2013-08-16 Ares Trading S.A. Stabilized interferon liquid formulations
US8247946B2 (en) 2004-06-14 2012-08-21 Massachusetts Institute Of Technology Electrochemical actuator
US7872396B2 (en) 2004-06-14 2011-01-18 Massachusetts Institute Of Technology Electrochemical actuator
US7999435B2 (en) * 2004-06-14 2011-08-16 Massachusetts Institute Of Technology Electrochemical actuator
WO2005124918A2 (en) 2004-06-14 2005-12-29 Massachusetts Institute Of Technology Electrochemical actuating methods, devices and structures
US7994686B2 (en) * 2004-06-14 2011-08-09 Massachusetts Institute Of Technology Electrochemical methods, devices, and structures
WO2006014425A1 (en) * 2004-07-02 2006-02-09 Biovalve Technologies, Inc. Methods and devices for delivering glp-1 and uses thereof
US8062250B2 (en) * 2004-08-10 2011-11-22 Unomedical A/S Cannula device
DE102004039408A1 (en) * 2004-08-13 2006-03-02 Disetronic Licensing Ag Insertion head for medical or pharmaceutical applications
CN101010112B (en) * 2004-09-02 2010-04-21 诺和诺德公司 Medical device adapted for detection of drug condition
WO2006032692A1 (en) 2004-09-22 2006-03-30 Novo Nordisk A/S Medical device with cannula inserter
US20080215006A1 (en) * 2004-09-22 2008-09-04 Novo Nordisk A/S Medical Device with Transcutaneous Cannula Device
CN101087625B (en) * 2004-11-22 2012-02-22 因特利杰克特有限公司 Devices and systems for medicament delivery
US10737028B2 (en) 2004-11-22 2020-08-11 Kaleo, Inc. Devices, systems and methods for medicament delivery
US11590286B2 (en) 2004-11-22 2023-02-28 Kaleo, Inc. Devices, systems and methods for medicament delivery
US7648483B2 (en) * 2004-11-22 2010-01-19 Intelliject, Inc. Devices, systems and methods for medicament delivery
JP4874989B2 (en) 2004-11-22 2012-02-15 ノヴォ ノルディスク アー/エス Soluble and stable insulin-containing formulation
US7947017B2 (en) 2004-11-22 2011-05-24 Intelliject, Inc. Devices, systems and methods for medicament delivery
CN100579598C (en) 2004-12-06 2010-01-13 诺和诺德公司 Ventilated skin mountable device
JP4964141B2 (en) * 2004-12-10 2012-06-27 ウノメディカル アクティーゼルスカブ Insertion tool
US20070027381A1 (en) * 2005-07-29 2007-02-01 Therasense, Inc. Inserter and methods of use
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US20100331646A1 (en) * 2009-06-30 2010-12-30 Abbott Diabetes Care Inc. Health Management Devices and Methods
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US7731657B2 (en) * 2005-08-30 2010-06-08 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US8571624B2 (en) * 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US20090105569A1 (en) 2006-04-28 2009-04-23 Abbott Diabetes Care, Inc. Introducer Assembly and Methods of Use
US20110190603A1 (en) * 2009-09-29 2011-08-04 Stafford Gary A Sensor Inserter Having Introducer
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US9636450B2 (en) * 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
EP1841476B1 (en) * 2005-01-17 2011-06-29 Novo Nordisk A/S Fluid delivery device with integrated monitoring of physiological characteristics
ES2908027T3 (en) 2005-01-24 2022-04-27 Antares Pharma Inc An injector with a pre-filled syringe
EP1848476A1 (en) 2005-01-24 2007-10-31 Novo Nordisk A/S Transcutaneous device assembly
PL2058020T3 (en) 2005-02-01 2013-03-29 Kaleo Inc Devices for medicament delivery
EP1866009A1 (en) 2005-02-25 2007-12-19 Novo Nordisk A/S Pump assembly with safety valve
US7985199B2 (en) 2005-03-17 2011-07-26 Unomedical A/S Gateway system
EP1863559A4 (en) * 2005-03-21 2008-07-30 Abbott Diabetes Care Inc Method and system for providing integrated medication infusion and analyte monitoring system
KR20070121731A (en) * 2005-03-21 2007-12-27 우노메디컬 에이/에스 A mounting pad, an adhesive device comprising such mounting pad, and methods of applying such devices to a patient
WO2006105794A1 (en) 2005-04-06 2006-10-12 M 2 Medical A/S An actuator
EP1877116A1 (en) 2005-04-13 2008-01-16 Novo Nordisk A/S Medical skin mountable device and system
US20080097291A1 (en) * 2006-08-23 2008-04-24 Hanson Ian B Infusion pumps and methods and delivery devices and methods with same
US8277415B2 (en) * 2006-08-23 2012-10-02 Medtronic Minimed, Inc. Infusion medium delivery device and method with drive device for driving plunger in reservoir
US8137314B2 (en) * 2006-08-23 2012-03-20 Medtronic Minimed, Inc. Infusion medium delivery device and method with compressible or curved reservoir or conduit
US7955305B2 (en) 2005-05-06 2011-06-07 Medtronic Minimed, Inc. Needle inserter and method for infusion device
US8512288B2 (en) * 2006-08-23 2013-08-20 Medtronic Minimed, Inc. Infusion medium delivery device and method with drive device for driving plunger in reservoir
US7905868B2 (en) * 2006-08-23 2011-03-15 Medtronic Minimed, Inc. Infusion medium delivery device and method with drive device for driving plunger in reservoir
US8840586B2 (en) * 2006-08-23 2014-09-23 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
EP1898975A2 (en) * 2005-05-13 2008-03-19 Novo Nordisk A/S Medical device adapted to detect disengagement of a transcutaneous device
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
DK1896097T3 (en) * 2005-06-28 2010-11-22 Unomedical As Packaging for infusion sets and method of using an infusion set
US8603034B2 (en) * 2005-07-12 2013-12-10 Applied Diabetes Research, Inc. One piece sealing reservoir for an insulin infusion pump
PL1762259T3 (en) 2005-09-12 2011-03-31 Unomedical As Inserter for an infusion set with a first and second spring units
DE502005009907D1 (en) * 2005-09-15 2010-08-26 Roche Diagnostics Gmbh Insertion head with handle
US9144645B2 (en) * 2005-09-21 2015-09-29 Applied Diabetes Research, Inc. One piece sealing reservoir for an insulin infusion pump
US8105279B2 (en) 2005-09-26 2012-01-31 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US7534226B2 (en) 2005-09-26 2009-05-19 M2 Group Holdings, Inc. Dispensing fluid from an infusion pump system
US8409142B2 (en) 2005-09-26 2013-04-02 Asante Solutions, Inc. Operating an infusion pump system
EP1933901B1 (en) 2005-09-26 2014-12-31 Asante Solutions, Inc. Portable infusion pump having a flexible pushrod with hinged portions
US8545445B2 (en) * 2006-02-09 2013-10-01 Deka Products Limited Partnership Patch-sized fluid delivery systems and methods
US9521968B2 (en) * 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US7756561B2 (en) * 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US8880138B2 (en) * 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
JP2009511223A (en) * 2005-10-17 2009-03-19 ノボ・ノルデイスク・エー/エス Vented drug reservoir unit
US7583190B2 (en) * 2005-10-31 2009-09-01 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
SI2926847T1 (en) * 2005-11-02 2022-10-28 Medicaltree Patents Ltd. Implantable infusion device with advanceable and retractable needle
WO2007056592A2 (en) 2005-11-08 2007-05-18 M2 Medical A/S Method and system for manual and autonomous control of an infusion pump
JP4768415B2 (en) * 2005-11-24 2011-09-07 テルモ株式会社 Puncture device
US20090118592A1 (en) * 2005-12-08 2009-05-07 Novo Nordisk A/S Medical System Comprising a Sensor Device
USD655807S1 (en) 2005-12-09 2012-03-13 Unomedical A/S Medical device
ATE429260T1 (en) * 2005-12-23 2009-05-15 Unomedical As ADMINISTRATION DEVICE
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US7549976B2 (en) * 2005-12-28 2009-06-23 Smiths Medical Md, Inc. Portal access device with removable sharps protection
EP1968432A4 (en) * 2005-12-28 2009-10-21 Abbott Diabetes Care Inc Medical device insertion
US20070264130A1 (en) * 2006-01-27 2007-11-15 Phluid, Inc. Infusion Pumps and Methods for Use
US20090218243A1 (en) * 2006-02-13 2009-09-03 Unomedical A/S Packing for Injection Device
NZ570115A (en) * 2006-02-28 2010-07-30 Unomedical As Inserter for infusion part and infusion part provided with needle protector
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
WO2007104755A1 (en) 2006-03-13 2007-09-20 Novo Nordisk A/S Secure pairing of electronic devices using dual means of communication
CA2646324C (en) 2006-03-30 2016-06-07 Valeritas, Llc Multi-cartridge fluid delivery device
WO2007122207A1 (en) 2006-04-26 2007-11-01 Novo Nordisk A/S Skin-mountable device in packaging comprising coated seal member
WO2007131013A1 (en) 2006-05-03 2007-11-15 Antares Pharma, Inc. Two-stage reconstituting injector
EP1857129B8 (en) * 2006-05-19 2009-09-02 Roche Diagnostics GmbH Adapter device for sticking a medical instrument to the skin surface
US20070282269A1 (en) * 2006-05-31 2007-12-06 Seattle Medical Technologies Cannula delivery apparatus and method for a disposable infusion device
US20070287960A1 (en) * 2006-05-31 2007-12-13 Seattle Medical Technologies Disposable infusion device with medicament level indicator
US7713262B2 (en) * 2006-05-31 2010-05-11 Calibra Medical, Inc. Disposable infusion device with linear peristaltic pump
US9399094B2 (en) * 2006-06-06 2016-07-26 Novo Nordisk A/S Assembly comprising skin-mountable device and packaging therefore
EP2023818A2 (en) * 2006-06-07 2009-02-18 Unomedical A/S Inserter for transcutaneous sensor
CN101489604B (en) * 2006-06-09 2012-05-23 优诺医疗有限公司 Mounting pad
CN101500627B (en) 2006-08-02 2012-03-14 优诺医疗有限公司 Cannula and delivery device
US20080051765A1 (en) * 2006-08-23 2008-02-28 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
US7828764B2 (en) * 2006-08-23 2010-11-09 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
US7789857B2 (en) * 2006-08-23 2010-09-07 Medtronic Minimed, Inc. Infusion medium delivery system, device and method with needle inserter and needle inserter device and method
US7794434B2 (en) * 2006-08-23 2010-09-14 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
US7811262B2 (en) * 2006-08-23 2010-10-12 Medtronic Minimed, Inc. Systems and methods allowing for reservoir filling and infusion medium delivery
US8870821B2 (en) * 2006-10-13 2014-10-28 Michael D. Laufer Device for tissue injection
EP1917990A1 (en) 2006-10-31 2008-05-07 Unomedical A/S Infusion set
US8579853B2 (en) * 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
CN101541359B (en) * 2006-11-21 2012-11-28 皇家飞利浦电子股份有限公司 Medicament delivery device, capsule and in vivo medicine delivery or diagnostic system
US20080161666A1 (en) * 2006-12-29 2008-07-03 Abbott Diabetes Care, Inc. Analyte devices and methods
AU2008209700A1 (en) * 2007-02-02 2008-08-07 Unomedical A/S A gateway device
EP2114492A1 (en) * 2007-03-06 2009-11-11 Novo Nordisk A/S Pump assembly comprising actuator system
DE502007005457D1 (en) * 2007-03-14 2010-12-09 Roche Diagnostics Gmbh Insertion head for medical or pharmaceutical applications
ATE477011T1 (en) * 2007-03-14 2010-08-15 Hoffmann La Roche INSERTION DEVICE FOR AN INSERTION HEAD, IN PARTICULAR FOR AN INFUSION SET
JP5102350B2 (en) * 2007-04-30 2012-12-19 メドトロニック ミニメド インコーポレイテッド Reservoir filling / bubble management / infusion medium delivery system and method using the system
US7959715B2 (en) * 2007-04-30 2011-06-14 Medtronic Minimed, Inc. Systems and methods allowing for reservoir air bubble management
US7963954B2 (en) 2007-04-30 2011-06-21 Medtronic Minimed, Inc. Automated filling systems and methods
US8323250B2 (en) * 2007-04-30 2012-12-04 Medtronic Minimed, Inc. Adhesive patch systems and methods
US8434528B2 (en) * 2007-04-30 2013-05-07 Medtronic Minimed, Inc. Systems and methods for reservoir filling
US8613725B2 (en) 2007-04-30 2013-12-24 Medtronic Minimed, Inc. Reservoir systems and methods
US8597243B2 (en) 2007-04-30 2013-12-03 Medtronic Minimed, Inc. Systems and methods allowing for reservoir air bubble management
ES2911529T3 (en) * 2007-05-07 2022-05-19 Unomedical As supply device
US7892199B2 (en) 2007-05-21 2011-02-22 Asante Solutions, Inc. Occlusion sensing for an infusion pump
US7833196B2 (en) * 2007-05-21 2010-11-16 Asante Solutions, Inc. Illumination instrument for an infusion pump
US7794426B2 (en) 2007-05-21 2010-09-14 Asante Solutions, Inc. Infusion pump system with contamination-resistant features
US7981102B2 (en) * 2007-05-21 2011-07-19 Asante Solutions, Inc. Removable controller for an infusion pump
WO2008150917A1 (en) * 2007-05-31 2008-12-11 Abbott Diabetes Care, Inc. Insertion devices and methods
US20100190706A1 (en) 2007-06-01 2010-07-29 Novo Nordisk A/S Stable Non-Aqueous Pharmaceutical Compositions
ES2351273T3 (en) * 2007-06-06 2011-02-02 Unomedical A/S PACKING THAT ALLOWS GAS STERILIZATION.
US20080312600A1 (en) * 2007-06-15 2008-12-18 Peter Krulevitch Flexible medical device conduit
EP2155296B1 (en) * 2007-06-20 2019-08-28 Unomedical A/S Cannula insertion device with automatic needle retraction comprising only one spring
DE202008017390U1 (en) 2007-06-20 2009-08-13 Unomedical A/S Catheter and device for making such a catheter
WO2009004026A1 (en) 2007-07-03 2009-01-08 Unomedical A/S Inserter having bistable equilibrium states
RU2010104457A (en) 2007-07-10 2011-08-20 Уномедикал А/С (Dk) TWO SPRING INPUT DEVICE
RU2010105684A (en) * 2007-07-18 2011-08-27 Уномедикал А/С (Dk) TURNING INTRODUCTION DEVICE
US7828771B2 (en) * 2007-07-26 2010-11-09 Entra Pharmaceuticals, Inc. Systems and methods for delivering drugs
US7717903B2 (en) 2007-09-06 2010-05-18 M2 Group Holdings, Inc. Operating an infusion pump system
US8032226B2 (en) 2007-09-07 2011-10-04 Asante Solutions, Inc. User profile backup system for an infusion pump device
US8287514B2 (en) 2007-09-07 2012-10-16 Asante Solutions, Inc. Power management techniques for an infusion pump system
US7935076B2 (en) 2007-09-07 2011-05-03 Asante Solutions, Inc. Activity sensing techniques for an infusion pump system
US8062256B2 (en) * 2007-09-28 2011-11-22 Calibra Medical, Inc. Disposable infusion device with medicament level indicator
US10420880B2 (en) 2007-10-02 2019-09-24 West Pharma. Services IL, Ltd. Key for securing components of a drug delivery system during assembly and/or transport and methods of using same
US9345836B2 (en) 2007-10-02 2016-05-24 Medimop Medical Projects Ltd. Disengagement resistant telescoping assembly and unidirectional method of assembly for such
US7967795B1 (en) 2010-01-19 2011-06-28 Lamodel Ltd. Cartridge interface assembly with driving plunger
WO2009044401A2 (en) 2007-10-02 2009-04-09 Yossi Gross External drug pump
US9656019B2 (en) * 2007-10-02 2017-05-23 Medimop Medical Projects Ltd. Apparatuses for securing components of a drug delivery system during transport and methods of using same
EP2209500B1 (en) * 2007-10-31 2015-07-22 Novo Nordisk A/S Non-porous material as sterilization barrier
ES2387236T3 (en) * 2007-12-20 2012-09-18 Merck Serono S.A. Pegylated interferon beta formulations
US8986253B2 (en) * 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
WO2009096855A1 (en) * 2008-01-28 2009-08-06 Milux Holding Sa Blood clot removal device, system, and method
EP2240140B8 (en) * 2008-01-29 2022-05-18 Implantica Patent Ltd. An apparatus for treating gerd
EP2452709B1 (en) * 2008-02-08 2022-01-19 Unomedical A/S Cannula part
US20110046456A1 (en) * 2008-02-08 2011-02-24 Hoerdum Elo Lau Assembly Comprising Inserter, Cannula Part and Base Part
US20090204077A1 (en) * 2008-02-13 2009-08-13 Hasted Soren B Moulded Connection Between Cannula and Delivery Part
NZ587111A (en) * 2008-02-13 2012-03-30 Unomedical As Infusion part including seal between cannula and fluid inlet or outlet
AU2009216703A1 (en) 2008-02-20 2009-08-27 Unomedical A/S Insertion device with horizontally moving part
BRPI0908258A2 (en) * 2008-02-25 2017-10-17 Unomedical As membrane completely covering an opening of a needle giving access to a space in a device, device and assembly comprising a device
US20090247982A1 (en) * 2008-03-27 2009-10-01 Lifescan Inc. Medical Device Mechanical Pump
WO2009143188A2 (en) * 2008-05-19 2009-11-26 Diperna Paul M Disposable pump reservoir and related methods
US20110005958A1 (en) * 2009-07-09 2011-01-13 Onpharma, Inc. METHODS AND SYSTEMS FOR ADJUSTING THE pH OF MEDICAL BUFFERING SOLUTIONS
WO2010003886A1 (en) * 2008-07-07 2010-01-14 Unomedical A/S Inserter for transcutaneous device
US8876755B2 (en) 2008-07-14 2014-11-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
ES2738539T3 (en) 2008-08-05 2020-01-23 Antares Pharma Inc Multi dose injector
CN102186515B (en) * 2008-08-18 2014-07-23 凯利宝医疗公司 Drug infusion system with reusable and disposable components
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US9393369B2 (en) 2008-09-15 2016-07-19 Medimop Medical Projects Ltd. Stabilized pen injector
US8408421B2 (en) * 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
AU2009293019A1 (en) * 2008-09-19 2010-03-25 Tandem Diabetes Care Inc. Solute concentration measurement device and related methods
US20110226652A1 (en) * 2008-09-29 2011-09-22 Richard Morgan Hickmott Packing for Inserter
US8509894B2 (en) 2008-10-10 2013-08-13 Milux Holding Sa Heart help device, system, and method
EP2346548B1 (en) * 2008-10-10 2021-06-16 MedicalTree Patent Ltd. Heart help device, and system
EP2349096B1 (en) 2008-10-10 2021-01-27 MedicalTree Patent Ltd. An improved artificial valve
WO2010042046A1 (en) 2008-10-10 2010-04-15 Milux Holding S.A. Apparatus, system and operation method for the treatment of female sexual dysfunction
US8874215B2 (en) 2008-10-10 2014-10-28 Peter Forsell System, an apparatus, and a method for treating a sexual dysfunctional female patient
US11123171B2 (en) * 2008-10-10 2021-09-21 Peter Forsell Fastening means for implantable medical control assembly
US20100145305A1 (en) * 2008-11-10 2010-06-10 Ruth Alon Low volume accurate injector
US20100130958A1 (en) * 2008-11-26 2010-05-27 David Kang Device and Methods for Subcutaneous Delivery of High Viscosity Fluids
KR20110127642A (en) 2008-12-22 2011-11-25 우노메디컬 에이/에스 Medical device comprising adhesive pad
US8152779B2 (en) * 2008-12-30 2012-04-10 Medimop Medical Projects Ltd. Needle assembly for drug pump
ES2688062T3 (en) 2009-01-12 2018-10-30 Becton, Dickinson And Company Infusion set and / or patch pump having at least one of a rigid internal permanence catheter with flexible features and / or a flexible catheter connection
US9375529B2 (en) * 2009-09-02 2016-06-28 Becton, Dickinson And Company Extended use medical device
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
US8807169B2 (en) 2009-02-12 2014-08-19 Picolife Technologies, Llc Flow control system for a micropump
US20100217233A1 (en) * 2009-02-20 2010-08-26 Ranft Elizabeth A Method and device to anesthetize an area
DK3714788T3 (en) * 2009-02-26 2023-04-17 Abbott Diabetes Care Inc Method for manufacturing improved analyte sensors
US8579865B2 (en) 2009-03-20 2013-11-12 Antares Pharma, Inc. Hazardous agent injection system
US8467972B2 (en) * 2009-04-28 2013-06-18 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
WO2010127052A1 (en) * 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Dynamic analyte sensor calibration based on sensor stability profile
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women
US10952836B2 (en) * 2009-07-17 2021-03-23 Peter Forsell Vaginal operation method for the treatment of urinary incontinence in women
US8939928B2 (en) 2009-07-23 2015-01-27 Becton, Dickinson And Company Medical device having capacitive coupling communication and energy harvesting
EP3689237B1 (en) * 2009-07-23 2021-05-19 Abbott Diabetes Care, Inc. Method of manufacturing and system for continuous analyte measurement
EP3284494A1 (en) 2009-07-30 2018-02-21 Tandem Diabetes Care, Inc. Portable infusion pump system
KR20120054598A (en) 2009-07-30 2012-05-30 우노메디컬 에이/에스 Inserter device with horizontal moving part
CA2766961A1 (en) 2009-08-07 2011-02-10 Unomedical A/S Delivery device with sensor and one or more cannulas
WO2011025999A1 (en) * 2009-08-29 2011-03-03 Abbott Diabetes Care Inc. Analyte sensor
WO2011026149A1 (en) * 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Mounting unit having a sensor and associated circuitry
CN102473276B (en) 2009-08-31 2016-04-13 雅培糖尿病护理公司 Medical treatment device and method
WO2011026130A1 (en) * 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Inserter device including rotor subassembly
US10092691B2 (en) 2009-09-02 2018-10-09 Becton, Dickinson And Company Flexible and conformal patch pump
USD811584S1 (en) 2009-09-15 2018-02-27 Medimop Medical Projects Ltd. Injector device
US10071196B2 (en) 2012-05-15 2018-09-11 West Pharma. Services IL, Ltd. Method for selectively powering a battery-operated drug-delivery device and device therefor
US10071198B2 (en) 2012-11-02 2018-09-11 West Pharma. Servicees IL, Ltd. Adhesive structure for medical device
US8157769B2 (en) * 2009-09-15 2012-04-17 Medimop Medical Projects Ltd. Cartridge insertion assembly for drug delivery system
WO2011041531A1 (en) 2009-09-30 2011-04-07 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
CN104474605B (en) * 2009-10-13 2017-12-19 瓦莱里塔斯公司 Fluid delivery system
ES2929490T3 (en) 2009-12-16 2022-11-29 Becton Dickinson Co self injection device
ES2537654T3 (en) 2009-12-16 2015-06-10 Becton Dickinson And Company Auto injection device
ES2714698T3 (en) 2009-12-16 2019-05-29 Becton Dickinson Co Auto injection device
CN102753213B (en) 2009-12-16 2015-04-29 贝克顿·迪金森公司 Self-injection device
IN2012DN05226A (en) 2009-12-16 2015-10-23 Becton Dickinson Co
US9717850B2 (en) 2009-12-16 2017-08-01 Becton, Dickinson And Company Self-injection device
US8348898B2 (en) 2010-01-19 2013-01-08 Medimop Medical Projects Ltd. Automatic needle for drug pump
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
KR20130038841A (en) 2010-03-19 2013-04-18 할로자임, 아이엔씨 Gas-pressured medication delivery device
WO2011162843A1 (en) 2010-03-24 2011-12-29 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
BR112012024635A2 (en) 2010-03-30 2017-08-08 Unomedical As medical device
US8337457B2 (en) 2010-05-05 2012-12-25 Springleaf Therapeutics, Inc. Systems and methods for delivering a therapeutic agent
US9452261B2 (en) 2010-05-10 2016-09-27 Medimop Medical Projects Ltd. Low volume accurate injector
AU2015203703B2 (en) * 2010-05-20 2018-01-18 Becton, Dickinson And Company Drug delivery device
AU2011256804B2 (en) * 2010-05-20 2013-10-17 Becton, Dickinson And Company Drug delivery device
AU2014200306B2 (en) * 2010-05-20 2015-04-02 Becton, Dickinson And Company Drug delivery device
USD669165S1 (en) 2010-05-27 2012-10-16 Asante Solutions, Inc. Infusion pump
HUE026173T2 (en) 2010-06-07 2016-05-30 Amgen Inc Drug delivery device
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US20110319861A1 (en) * 2010-06-29 2011-12-29 Robert Wilk Medical device mechanical pump
US8260427B2 (en) 2010-07-07 2012-09-04 ProNerve, LLC Garment to facilitate needle electrode placement for intraoperative monitoring
EP2611478B1 (en) 2010-09-02 2022-08-17 Becton, Dickinson and Company Self-injection device having needle cover with activation preventer
US20120071837A1 (en) * 2010-09-21 2012-03-22 O'connor Sean Auto injector for medication
US8585677B2 (en) 2010-09-21 2013-11-19 Brigham Young University Laminar injection apparatus and method
US8915879B2 (en) 2010-09-24 2014-12-23 Perqflo, Llc Infusion pumps
US9216249B2 (en) 2010-09-24 2015-12-22 Perqflo, Llc Infusion pumps
US9498573B2 (en) 2010-09-24 2016-11-22 Perqflo, Llc Infusion pumps
US8777901B2 (en) 2010-09-24 2014-07-15 Perqflo, Llc Infusion pumps
EP2433663A1 (en) 2010-09-27 2012-03-28 Unomedical A/S Insertion system
EP2436412A1 (en) 2010-10-04 2012-04-04 Unomedical A/S A sprinkler cannula
WO2012059457A1 (en) * 2010-11-03 2012-05-10 Sanofi-Aventis Deutschland Gmbh Medicated module for administering fixed dose
US8905972B2 (en) 2010-11-20 2014-12-09 Perqflo, Llc Infusion pumps
US9950109B2 (en) 2010-11-30 2018-04-24 Becton, Dickinson And Company Slide-activated angled inserter and cantilevered ballistic insertion for intradermal drug infusion
US8814831B2 (en) 2010-11-30 2014-08-26 Becton, Dickinson And Company Ballistic microneedle infusion device
US8795230B2 (en) 2010-11-30 2014-08-05 Becton, Dickinson And Company Adjustable height needle infusion device
CA2821979A1 (en) 2010-12-17 2012-06-21 Yet-Ming Chiang Electrochemical actuators
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US9084849B2 (en) 2011-01-26 2015-07-21 Kaleo, Inc. Medicament delivery devices for administration of a medicament within a prefilled syringe
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8852152B2 (en) 2011-02-09 2014-10-07 Asante Solutions, Inc. Infusion pump systems and methods
US8454581B2 (en) 2011-03-16 2013-06-04 Asante Solutions, Inc. Infusion pump systems and methods
USD702834S1 (en) 2011-03-22 2014-04-15 Medimop Medical Projects Ltd. Cartridge for use in injection device
CN103619378B (en) * 2011-04-21 2017-03-01 艾伯维公司 wearable automatic injection device
US20120283668A1 (en) * 2011-05-04 2012-11-08 Pinchas Shalev Apparatus and method for using effervescent tablets for cosmetic care
EP2535073A1 (en) * 2011-06-16 2012-12-19 F. Hoffmann-La Roche AG Transport and transfer container for a fluid medium
US8496619B2 (en) 2011-07-15 2013-07-30 Antares Pharma, Inc. Injection device with cammed ram assembly
US9220660B2 (en) 2011-07-15 2015-12-29 Antares Pharma, Inc. Liquid-transfer adapter beveled spike
US9814832B2 (en) 2011-09-02 2017-11-14 Unl Holdings Llc Drive mechanism for drug delivery pumps with integrated status indication
CA2845379C (en) 2011-09-02 2019-08-06 Unitract Syringe Pty Ltd Insertion mechanism for a drug delivery pump
BR112014004530A2 (en) 2011-09-02 2017-03-28 Unitract Syringe Pty Ltd drive mechanism for integrated state indication drug delivery pumps
US9707335B2 (en) 2011-09-02 2017-07-18 Unitract Syringe Pty Ltd Drive mechanism for drug delivery pumps with integrated status indication
US11173244B2 (en) 2011-09-02 2021-11-16 Unl Holdings Llc Drive mechanism for drug delivery pumps with integrated status indication
JP6411888B2 (en) * 2011-09-07 2018-10-24 スリーエム イノベイティブ プロパティズ カンパニー Delivery system for hollow microneedle array
US8808230B2 (en) 2011-09-07 2014-08-19 Asante Solutions, Inc. Occlusion detection for an infusion pump system
JP2014528791A (en) 2011-09-13 2014-10-30 ユニトラクト シリンジ プロプライエタリイ リミテッドUnitract Syringe Pty Ltd Sterile fluid path connection to a drug container for a drug delivery pump
WO2013050277A1 (en) 2011-10-05 2013-04-11 Unomedical A/S Inserter for simultaneous insertion of multiple transcutaneous parts
EP2583715A1 (en) 2011-10-19 2013-04-24 Unomedical A/S Infusion tube system and method for manufacture
US9440051B2 (en) 2011-10-27 2016-09-13 Unomedical A/S Inserter for a multiplicity of subcutaneous parts
US8771229B2 (en) 2011-12-01 2014-07-08 Picolife Technologies, Llc Cartridge system for delivery of medicament
US8790307B2 (en) 2011-12-01 2014-07-29 Picolife Technologies, Llc Drug delivery device and methods therefor
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US10335545B2 (en) 2012-01-31 2019-07-02 West Pharma. Services IL, Ltd. Time dependent drug delivery apparatus
WO2013134279A1 (en) 2012-03-05 2013-09-12 Becton, Dickinson And Company Wireless communication for on-body medical devices
US10130759B2 (en) 2012-03-09 2018-11-20 Picolife Technologies, Llc Multi-ported drug delivery device having multi-reservoir cartridge system
MX2014010944A (en) 2012-03-12 2014-11-13 Unitract Syringe Pty Ltd Fill-finish cartridges for sterile fluid pathway assemblies and drug delivery devices incorporating fill-finish cartridges.
US9463280B2 (en) 2012-03-26 2016-10-11 Medimop Medical Projects Ltd. Motion activated septum puncturing drug delivery device
US9072827B2 (en) 2012-03-26 2015-07-07 Medimop Medical Projects Ltd. Fail safe point protector for needle safety flap
US10668213B2 (en) 2012-03-26 2020-06-02 West Pharma. Services IL, Ltd. Motion activated mechanisms for a drug delivery device
WO2013146215A1 (en) * 2012-03-30 2013-10-03 テルモ株式会社 Medical solution administration device
EP2833944A4 (en) 2012-04-06 2016-05-25 Antares Pharma Inc Needle assisted jet injection administration of testosterone compositions
EP2650032A1 (en) * 2012-04-11 2013-10-16 PharmaSens AG Subcutaneous needle insertion mechanism
IN2014DN08619A (en) 2012-04-13 2015-05-22 Becton Dickinson Co
US9883834B2 (en) 2012-04-16 2018-02-06 Farid Amirouche Medication delivery device with multi-reservoir cartridge system and related methods of use
US9364610B2 (en) 2012-05-07 2016-06-14 Antares Pharma, Inc. Injection device with cammed ram assembly
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9522235B2 (en) 2012-05-22 2016-12-20 Kaleo, Inc. Devices and methods for delivering medicaments from a multi-chamber container
US10245420B2 (en) 2012-06-26 2019-04-02 PicoLife Technologies Medicament distribution systems and related methods of use
US8454557B1 (en) 2012-07-19 2013-06-04 Asante Solutions, Inc. Infusion pump system and method
US8454562B1 (en) 2012-07-20 2013-06-04 Asante Solutions, Inc. Infusion pump system and method
US9867929B2 (en) 2012-08-15 2018-01-16 Becton, Dickinson And Company Pump engine with metering system for dispensing liquid medication
WO2014036285A2 (en) 2012-08-29 2014-03-06 Unitract Syringe Pty Ltd Variable rate controlled delivery drive mechanisms for drug delivery pumps
USD745142S1 (en) 2012-08-30 2015-12-08 Unitract Syringe Pty Ltd Drug delivery pump
WO2014046950A1 (en) 2012-09-24 2014-03-27 Enable Injections, Llc Medication vial and injector assemblies and methods of use
US9321581B2 (en) 2012-10-12 2016-04-26 Eli Lilly And Company Process and device for delivery of fluid by chemical reaction
AU2013328883B2 (en) 2012-10-12 2018-08-02 Eli Lilly And Company Chemical engines and methods for their use, especially in the injection of highly viscous fluids
US9427523B2 (en) 2012-12-10 2016-08-30 Bigfoot Biomedical, Inc. Infusion pump system and method
US20140276536A1 (en) 2013-03-14 2014-09-18 Asante Solutions, Inc. Infusion Pump System and Methods
US10549079B2 (en) 2012-12-21 2020-02-04 3M Innovative Properties Company Adhesive assemblies and microneedle injection apparatuses comprising same
US9421323B2 (en) 2013-01-03 2016-08-23 Medimop Medical Projects Ltd. Door and doorstop for portable one use drug delivery apparatus
USD723157S1 (en) 2013-03-12 2015-02-24 Unitract Syringe Pty Ltd Drug delivery pump
JP6273655B2 (en) 2013-01-25 2018-02-07 ユーエヌエル ホールディングス エルエルシーUNL Holdings LLC Integrated fluid pathway connection and drug container
DK2953667T3 (en) 2013-02-11 2020-01-27 Antares Pharma Inc Needle-assisted jet injection device with reduced triggering power
US9446186B2 (en) 2013-03-01 2016-09-20 Bigfoot Biomedical, Inc. Operating an infusion pump system
ES2742046T3 (en) 2013-03-11 2020-02-12 Antares Pharma Inc Dose injector with pinion system
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US10201662B2 (en) 2013-04-10 2019-02-12 Sanofi Injection device and assembly method
US9011164B2 (en) 2013-04-30 2015-04-21 Medimop Medical Projects Ltd. Clip contact for easy installation of printed circuit board PCB
US9889256B2 (en) 2013-05-03 2018-02-13 Medimop Medical Projects Ltd. Sensing a status of an infuser based on sensing motor control and power input
ES2935038T3 (en) 2013-05-03 2023-03-01 Becton Dickinson Co drug delivery device
US9446187B2 (en) 2013-06-03 2016-09-20 Bigfoot Biomedical, Inc. Infusion pump system and method
US9457141B2 (en) 2013-06-03 2016-10-04 Bigfoot Biomedical, Inc. Infusion pump system and method
DK3010568T3 (en) 2013-06-18 2019-05-06 Enable Injections Inc Device for transfer with vial and injection
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
MX370074B (en) 2013-08-23 2019-11-29 Unitract Syringe Pty Ltd Integrated pierceable seal fluid pathway connection and drug containers for drug delivery pumps.
US9119939B2 (en) * 2013-09-12 2015-09-01 Michael J. Botich Rotatable hypodermic needle and method of use
AU2014340174B2 (en) 2013-10-24 2019-09-12 Amgen Inc. Drug delivery system with temperature-sensitive control
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
CA2933166C (en) 2013-12-31 2020-10-27 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
EP3102259B1 (en) 2014-02-03 2020-03-25 UNL Holdings LLC Expanding plunger rods for syringes
GB201402261D0 (en) * 2014-02-10 2014-03-26 Owen Mumford Ltd Injector apparatus
CN104888288A (en) 2014-03-07 2015-09-09 精工爱普生株式会社 Skin-patch type infusion pump
US10004845B2 (en) 2014-04-18 2018-06-26 Becton, Dickinson And Company Split piston metering pump
EP3151883A1 (en) 2014-06-03 2017-04-12 Amgen Inc. Devices and methods for assisting a user of a drug delivery device
US9629901B2 (en) 2014-07-01 2017-04-25 Bigfoot Biomedical, Inc. Glucagon administration system and methods
US9416775B2 (en) 2014-07-02 2016-08-16 Becton, Dickinson And Company Internal cam metering pump
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US10137246B2 (en) 2014-08-06 2018-11-27 Bigfoot Biomedical, Inc. Infusion pump assembly and method
US9919096B2 (en) 2014-08-26 2018-03-20 Bigfoot Biomedical, Inc. Infusion pump system and method
US11464899B2 (en) 2014-08-28 2022-10-11 Becton, Dickinson And Company Wireless communication for on-body medical devices
EP3193974A1 (en) * 2014-09-15 2017-07-26 Sanofi Injection devices with tissue sewelling detection
EP3193973A1 (en) * 2014-09-15 2017-07-26 Sanofi Medicament delivery device with rotatable housing on a base
EP3197336B1 (en) 2014-09-25 2020-12-23 Progenity, Inc. Electromechanical pill device with localization capabilities
AU2015323994A1 (en) 2014-09-29 2017-05-18 Unl Holdings Llc Rigid needle insertion mechanism for a drug delivery pump
US10159786B2 (en) 2014-09-30 2018-12-25 Perqflo, Llc Hybrid ambulatory infusion pumps
WO2016054015A1 (en) * 2014-09-30 2016-04-07 The Regents Of The University Of California Active agent delivery devices and methods of using the same
JP6282209B2 (en) * 2014-10-08 2018-02-21 日本ライフライン株式会社 Chemical ablation device and chemical ablation system
TWD174377S (en) 2014-11-07 2016-03-11 優尼翠克注射器有限公司 Portion of drug delivery device (1)
EP3689394A1 (en) 2014-12-19 2020-08-05 Amgen Inc. Drug delivery device with live button or user interface field
US10799630B2 (en) 2014-12-19 2020-10-13 Amgen Inc. Drug delivery device with proximity sensor
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
EP3258989B1 (en) 2015-02-18 2020-01-01 Medtronic Minimed, Inc. Ambulatory infusion pump with static and dynamic seals
US9795534B2 (en) 2015-03-04 2017-10-24 Medimop Medical Projects Ltd. Compliant coupling assembly for cartridge coupling of a drug delivery device
US10251813B2 (en) 2015-03-04 2019-04-09 West Pharma. Services IL, Ltd. Flexibly mounted cartridge alignment collar for drug delivery device
JP6799001B2 (en) 2015-03-10 2020-12-09 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. Injection device
CA2980004C (en) 2015-03-24 2023-10-10 Kaleo, Inc. Devices and methods for delivering a lyophilized medicament
US10293120B2 (en) 2015-04-10 2019-05-21 West Pharma. Services IL, Ltd. Redundant injection device status indication
US9744297B2 (en) 2015-04-10 2017-08-29 Medimop Medical Projects Ltd. Needle cannula position as an input to operational control of an injection device
US9878097B2 (en) 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
CA2984939A1 (en) 2015-05-14 2016-11-17 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10149943B2 (en) 2015-05-29 2018-12-11 West Pharma. Services IL, Ltd. Linear rotation stabilizer for a telescoping syringe stopper driverdriving assembly
USD794770S1 (en) 2015-06-26 2017-08-15 Unitract Syringe Pty Ltd Drug delivery pump
EP3316928B1 (en) 2015-06-30 2022-10-19 Kaleo, Inc. Auto-injectors for administration of a medicament within a prefilled syringe
FR3038232B1 (en) * 2015-06-30 2017-07-28 Crossject INJECTION DEVICE WITHOUT NEEDLE EQUIPPED WITH A COMPRESSION SPRING
FR3038231B1 (en) * 2015-06-30 2017-07-28 Crossject NEEDLE-FREE INJECTION DEVICE EQUIPPED WITH IMPROVED SEALING MEMBRANE
USD794771S1 (en) 2015-07-10 2017-08-15 Unitract Syringe Pty Ltd. Drug delivery pump
USD776264S1 (en) 2015-07-30 2017-01-10 Becton, Dickinson And Company Medical injector
USD774640S1 (en) 2015-07-30 2016-12-20 Becton, Dickinson And Company Medical injector
USD767120S1 (en) 2015-07-30 2016-09-20 Becton, Dickinson And Company Medical injector
USD776263S1 (en) 2015-07-30 2017-01-10 Becton, Dickinson And Company Medical injector
USD794776S1 (en) 2015-07-30 2017-08-15 Becton, Dickinson And Company Medical injector
USD776262S1 (en) 2015-07-30 2017-01-10 Becton, Dickinson And Company Medical injector
USD776265S1 (en) 2015-07-30 2017-01-10 Becton, Dickinson And Company Medical injector
CN107029317B (en) * 2015-07-31 2020-07-28 重庆倍加医疗器械有限公司 Medicine injector
US10576207B2 (en) 2015-10-09 2020-03-03 West Pharma. Services IL, Ltd. Angled syringe patch injector
US9987432B2 (en) 2015-09-22 2018-06-05 West Pharma. Services IL, Ltd. Rotation resistant friction adapter for plunger driver of drug delivery device
US10086145B2 (en) 2015-09-22 2018-10-02 West Pharma Services Il, Ltd. Rotation resistant friction adapter for plunger driver of drug delivery device
CN108430536B (en) * 2015-10-09 2022-04-08 西医药服务以色列分公司 Method of filling a custom syringe
HUE056371T2 (en) * 2015-11-11 2022-02-28 Hoffmann La Roche Transfilling device
DK3380151T3 (en) * 2015-11-27 2021-01-25 Sanofi Aventis Deutschland DEVICE FOR INJECTION OF MEDICINAL PRODUCTS WITH A ROTARY NEEDLE HOLDER
CA3009853C (en) * 2015-12-29 2023-08-01 Gajanan Kulkarni Transdermal microneedle drug delivery device and method
US10449294B1 (en) 2016-01-05 2019-10-22 Bigfoot Biomedical, Inc. Operating an infusion pump system
CA3009409A1 (en) 2016-01-05 2017-07-13 Bigfoot Biomedical, Inc. Operating multi-modal medicine delivery systems
JP6885960B2 (en) 2016-01-21 2021-06-16 ウェスト ファーマ サービシーズ イスラエル リミテッド Drug delivery device with visual indicators
WO2017127215A1 (en) 2016-01-21 2017-07-27 Medimop Medical Projects Ltd. Needle insertion and retraction mechanism
CN111544704B (en) 2016-01-21 2022-06-03 西医药服务以色列有限公司 Force containment in autoinjectors
JP7069023B2 (en) 2016-02-12 2022-05-17 メドトロニック ミニメド インコーポレイテッド Carrying injection pump and assembly for use with it
USD809134S1 (en) 2016-03-10 2018-01-30 Bigfoot Biomedical, Inc. Infusion pump assembly
WO2017161076A1 (en) 2016-03-16 2017-09-21 Medimop Medical Projects Ltd. Staged telescopic screw assembly having different visual indicators
US10376647B2 (en) 2016-03-18 2019-08-13 West Pharma. Services IL, Ltd. Anti-rotation mechanism for telescopic screw assembly
US11541168B2 (en) 2016-04-29 2023-01-03 Amgen Inc. Drug delivery device with messaging label
EP3463510B1 (en) * 2016-05-26 2019-11-13 Insulet Corporation Single dose drug delivery device
GB2550924A (en) 2016-05-31 2017-12-06 Ndm Technologies Ltd Improvements in or relating to transdermal delivery
JP6957525B2 (en) 2016-06-02 2021-11-02 ウェスト ファーマ サービシーズ イスラエル リミテッド Needle evacuation by 3 positions
JP6869327B2 (en) 2016-08-01 2021-05-12 ウェスト ファーマ サービシーズ イスラエル リミテッド Anti-rotation cartridge
EP3490635B1 (en) 2016-08-01 2021-11-17 West Pharma. Services Il, Ltd. Partial door closure prevention spring
IL264404B (en) 2016-08-08 2022-07-01 Unitract Syringe Pty Ltd Drug delivery device and method for connecting a fluid flowpath
WO2018034784A1 (en) 2016-08-17 2018-02-22 Amgen Inc. Drug delivery device with placement detection
US10695487B2 (en) 2016-08-30 2020-06-30 Unl Holdings Llc Controlled delivery drive mechanisms for drug delivery pumps
EP3509469A1 (en) 2016-09-09 2019-07-17 Progenity, Inc. Electromechanical ingestible device for delivery of a dispensable substance
US10926025B2 (en) 2016-09-15 2021-02-23 Tandem Diabetes Care, Inc. Vial supporter for medicament pump
USD851244S1 (en) 2016-09-26 2019-06-11 West Pharma. Services IL, Ltd. Syringe barrel
USD838367S1 (en) 2016-09-26 2019-01-15 West Pharma. Services IL, Ltd. Syringe barrel
US20200016333A1 (en) * 2016-09-27 2020-01-16 Sanofi-Aventis Deutschland Gmbh A medicament delivery device
US10426896B2 (en) 2016-09-27 2019-10-01 Bigfoot Biomedical, Inc. Medicine injection and disease management systems, devices, and methods
EP3305349B1 (en) 2016-10-10 2020-09-23 Medimop Medical Projects Ltd Pharmaceutical cartridge
US10610639B2 (en) 2016-10-10 2020-04-07 West Pharma. Services IL, Ltd. Needle insertion and retraction mechanism
GB2556633A (en) * 2016-11-18 2018-06-06 Owen Mumford Ltd Medicament delivery device
AU2017373857A1 (en) * 2016-12-05 2019-06-13 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
EP3551047A1 (en) 2016-12-07 2019-10-16 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
USD836769S1 (en) 2016-12-12 2018-12-25 Bigfoot Biomedical, Inc. Insulin delivery controller
AU2017376111B2 (en) 2016-12-12 2023-02-02 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
WO2018119218A1 (en) 2016-12-23 2018-06-28 Kaleo, Inc. Medicament delivery device and methods for delivering drugs to infants and children
WO2018136898A1 (en) 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US11925790B2 (en) 2017-02-17 2024-03-12 Eli Lilly And Company Processes and devices for delivery of fluid by chemical reaction
CA3055762A1 (en) 2017-03-31 2018-10-04 Progenity, Inc. Localization systems and methods for an ingestible device
FR3064919B1 (en) * 2017-04-10 2020-07-10 Aptar France Sas DEVICE FOR AUTOMATIC INJECTION OF FLUID PRODUCT.
JP7169991B2 (en) 2017-05-05 2022-11-11 リジェネロン・ファーマシューティカルズ・インコーポレイテッド self-injector
CN110869072B (en) 2017-05-30 2021-12-10 西部制药服务有限公司(以色列) Modular drive mechanism for a wearable injector
USD839294S1 (en) 2017-06-16 2019-01-29 Bigfoot Biomedical, Inc. Display screen with graphical user interface for closed-loop medication delivery
US11389088B2 (en) 2017-07-13 2022-07-19 Bigfoot Biomedical, Inc. Multi-scale display of blood glucose information
EP3664863A2 (en) * 2017-08-09 2020-06-17 Amgen Inc. Hydraulic-pneumatic pressurized chamber drug delivery system
CA3073835A1 (en) 2017-08-30 2019-03-07 Pirouette Medical LLC Compact auto-injector
EP3681562B1 (en) * 2017-09-15 2020-12-23 West Pharma. Services Il, Ltd. Patch injector
WO2019071129A1 (en) 2017-10-05 2019-04-11 Pirouette Medical LLC Protective case for an auto-injector
WO2019089178A1 (en) 2017-11-06 2019-05-09 Amgen Inc. Drug delivery device with placement and flow sensing
JP7402799B2 (en) 2017-12-22 2023-12-21 ウェスト ファーマ サービシーズ イスラエル リミテッド Syringes available with different cartridge sizes
US11583633B2 (en) 2018-04-03 2023-02-21 Amgen Inc. Systems and methods for delayed drug delivery
WO2019232077A1 (en) 2018-05-29 2019-12-05 Chrono Therapeutics Inc. Drug delivery methods and systems
EP3866892A4 (en) * 2018-10-16 2022-07-20 Koglo Ltd. System and method for substance delivery
CN116726361A (en) 2018-11-19 2023-09-12 比奥拉治疗股份有限公司 Methods and devices for treating diseases with biologic therapeutic agents
KR20210109582A (en) * 2018-12-27 2021-09-06 폴리 메디큐어 리미티드 needle with safety mechanism
US20220062533A1 (en) * 2019-01-07 2022-03-03 Shl Medical Ag Medicament delivery device
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
EP4009936A4 (en) 2019-08-09 2023-08-09 Kaleo, Inc. Devices and methods for delivery of substances within a prefilled syringe
CN115666704A (en) 2019-12-13 2023-01-31 比奥拉治疗股份有限公司 Ingestible device for delivery of therapeutic agents to the gastrointestinal tract
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter
USD1007676S1 (en) 2021-11-16 2023-12-12 Regeneron Pharmaceuticals, Inc. Wearable autoinjector

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390246A (en) * 1940-10-18 1945-12-04 Marvin L Folkman Syringe
US2408323A (en) * 1943-06-10 1946-09-24 Margaret L Lockhart Hypodermic syringe
US2545017A (en) * 1947-06-02 1951-03-13 Gordon D Billingsley Hypodermic syringe
US2605765A (en) * 1947-06-05 1952-08-05 Kollsman Paul Automatic syringe
US2576951A (en) * 1950-09-29 1951-12-04 Compule Corp Hypodermic syringe assemblies, including plural-compartment admixing ampoules for segregated storage of ingredients of liquid mediginal solutions and parts thereof
GB718837A (en) * 1951-07-18 1954-11-24 Cook Waite Lab Inc Improvements in or relating to hypodermic syringe
US2880723A (en) * 1954-02-09 1959-04-07 Becton Dickinson Co Syringe assembly
GB995605A (en) * 1960-08-04 1965-06-23 Amalgamated Dental Co Ltd Improvements relating to hypodermic injection apparatus
FR2243705A1 (en) * 1973-09-14 1975-04-11 Mussard Pierre Dental syringe for painless injections - with simultaneous penetration of needle and ejection of anaesthetic liq
US4140117A (en) * 1975-05-12 1979-02-20 Alza Corporation Cartridge for liquid infusion apparatus
US4403987A (en) * 1982-01-25 1983-09-13 Gottinger Company, Inc. Device for aiding injection of a hypodermic syringe
EP0098592A3 (en) * 1982-07-06 1985-08-21 Fujisawa Pharmaceutical Co., Ltd. Portable artificial pancreas
US4753651A (en) * 1982-08-30 1988-06-28 Alza Corporation Self-driven pump
US4522622A (en) * 1982-12-23 1985-06-11 Alza Corporation Multiple fluid pulse dispenser
US4622031A (en) * 1983-08-18 1986-11-11 Drug Delivery Systems Inc. Indicator for electrophoretic transcutaneous drug delivery device
US4697622A (en) * 1984-06-01 1987-10-06 Parker Hannifin Corporation Passive filling device
US4684365A (en) * 1985-01-24 1987-08-04 Eaton Corporation Disposable refill unit for implanted medication infusion device
US4627445A (en) * 1985-04-08 1986-12-09 Garid, Inc. Glucose medical monitoring system
US4687423A (en) * 1985-06-07 1987-08-18 Ivac Corporation Electrochemically-driven pulsatile drug dispenser
CA1283827C (en) * 1986-12-18 1991-05-07 Giorgio Cirelli Appliance for injection of liquid formulations
US4734092A (en) * 1987-02-18 1988-03-29 Ivac Corporation Ambulatory drug delivery device
US4902278A (en) * 1987-02-18 1990-02-20 Ivac Corporation Fluid delivery micropump
US5070886A (en) * 1988-01-22 1991-12-10 Safety Diagnostice, Inc. Blood collection and testing means
US4894054A (en) * 1988-06-20 1990-01-16 Miskinyar Shir A Preloaded automatic disposable syringe
IT1231916B (en) * 1989-05-29 1992-01-15 Ampliscientifica S R L WEARABLE ARTIFICIAL PANCREAS
FR2649617A1 (en) * 1989-07-12 1991-01-18 Veprol DEVICE FOR DELIVERING A PHARMACOLOGICAL ACTIVE PRINCIPLE BY ELECTROLYTIC PUMPING
US5146091A (en) * 1990-04-19 1992-09-08 Inomet, Inc. Body fluid constituent measurement utilizing an interference pattern
US5135507A (en) * 1990-05-10 1992-08-04 Habley Medical Technology Corporation One-piece syringe
US5090963A (en) * 1990-10-19 1992-02-25 Product Development (Z.G.S.) Ltd. Electrochemically driven metering medicament dispenser
US5279544A (en) * 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
US5156591A (en) * 1990-12-13 1992-10-20 S. I. Scientific Innovations Ltd. Skin electrode construction and transdermal drug delivery device utilizing same
SE9101022D0 (en) * 1991-01-09 1991-04-08 Paal Svedman MEDICAL SUSPENSION DEVICE
US5562613A (en) * 1991-07-02 1996-10-08 Intermed, Inc. Subcutaneous drug delivery device
JPH07502424A (en) * 1991-10-24 1995-03-16 インステック・インコーポレイテッド Gas pressure driven leaching device by hydrogel electrolysis
US5336201A (en) * 1992-06-29 1994-08-09 Baxter International Inc. Syringe driving apparatus
US5318557A (en) * 1992-07-13 1994-06-07 Elan Medical Technologies Limited Medication administering device
US5267963A (en) * 1992-08-21 1993-12-07 Nicholas Bachynsky Medication injection device
TW245642B (en) * 1992-09-29 1995-04-21 Alza Corp
US5545143A (en) * 1993-01-21 1996-08-13 T. S. I. Medical Device for subcutaneous medication delivery
JP3199524B2 (en) * 1993-08-06 2001-08-20 日本メジフィジックス株式会社 Luer needle unit and syringe
FR2708858B1 (en) * 1993-08-09 1995-09-08 Zambon France Sa Infusion device with protective fins.
US5582184A (en) * 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
US5368578A (en) * 1994-03-10 1994-11-29 Sterling Winthrop Inc. Hypodermic syringe holder
US5390671A (en) * 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5507730A (en) * 1994-10-04 1996-04-16 Habley Medical Technology Corporation One-piece glass prefilled syringe system
US5568806A (en) * 1995-02-16 1996-10-29 Minimed Inc. Transcutaneous sensor insertion set
CA2151407A1 (en) * 1995-06-09 1996-12-10 Duncan Newman Injection device

Also Published As

Publication number Publication date
DE69620257D1 (en) 2002-05-02
WO1997021457A1 (en) 1997-06-19
ATE214954T1 (en) 2002-04-15
ZA9610374B (en) 1997-06-23
EP0902696A1 (en) 1999-03-24
TW317503B (en) 1997-10-11
IL124470A0 (en) 1998-12-06
US5858001A (en) 1999-01-12
JP2000515394A (en) 2000-11-21
EP0902696B1 (en) 2002-03-27
AU1808797A (en) 1997-07-03
DE69620257T2 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
CA2238614A1 (en) Cartridge-based drug delivery device
US11642456B2 (en) Hydraulically actuated pump for fluid administration
US6485461B1 (en) Disposable infusion device
EP1631336B1 (en) Pivotable injection needle unit
US7780636B2 (en) Portable drug delivery device having an encapsulated needle
EP1624914B1 (en) Internal needle inserter
US8684968B2 (en) Hypodermic drug delivery reservoir and apparatus
JP2648314B2 (en) Portable device for subcutaneous or intradermal injection
US6099504A (en) Pre-filled injection delivery device
CA3081685C (en) Low dose prefilled drug delivery device and method
US20080215006A1 (en) Medical Device with Transcutaneous Cannula Device
EP1495775A1 (en) Portable drug delivery device having an encapsulated needle
JP2019150594A (en) Needle control and drug mixing systems for fluid supply device
EA019609B1 (en) Auto-injector with filling means
AU2021261871A1 (en) Connector for aseptic transfer of fluid
US11596736B1 (en) Dual needle delivery system that connects and deploys needles of a medication delivery device
CN117618711A (en) Automatic infusion device
WO2022240749A1 (en) On-body medicament delivery devices for administration of medicament
WO2005058392A2 (en) Cartridge for delivery device

Legal Events

Date Code Title Description
FZDE Discontinued